Recent Releases - AAD News Releases 2009-11-07T01:32:48-08:00 tag:aad.org,2009:news/ American Academy of Dermatology Dermatologists Launch New Web Site and Game to Teach Kids about Healthy Skin, Hair and Nail Habits2009-11-02T12:00:00-08:00A unique new Web site created by dermatologists lets kids learn how to practice good skin care virtually, or risk the consequences of pimples, greasy hair, a poison ivy rash and sunburn. The interactive game, “It’s a Skin Cell’s Life,” is just one of the many features on the American Academy of Dermatology’s (Academy) new Web site www.KidsSkinHealth.org, which provides information about caring for skin, hair and nails to kids ages 8-12 and their parents.

 “The Academy is committed to teaching children and their parents about skin, hair and nail care, and an interactive and engaging Web site is the perfect way to do that,” said dermatologist David M. Pariser, MD, FAAD, president of the Academy.  “The Web site, which was created with feedback from children and their parents, helps us encourage the development of lifelong habits that ensure good health, such as using sunscreen for protection against the harmful rays of the sun.”

The KidsSkinHealth.org home page features two portals: For Kids and For Grown Ups.

  • Kids Portal – Sammy the Skin Cell guides kids through the site, which explains how skin, hair and nails work, and how to take care of them.  There’s information on conditions that can affect them as well as fun facts, answers to common questions and a dictionary that includes audio pronunciations courtesy of Sammy. Kids can play “It’s a Skin Cell’s Life” as the avatar Sammy or Suzy the Skin Cell and earn points by using their new-found knowledge to take care of their avatars, search for words, test skin knowledge, catch bugs, explore mazes and zap ultraviolet rays.
  • Grown Ups Portal – Paralleling the information on the Kids Portal, the site guides parents in helping their children care for their skin, hair and nails, and provides information about adult conditions, such as rosacea and psoriasis, and how to care for aging skin.  The site also includes activities for parents to do with their children and answers to common questions.

To develop the Web site, the Academy surveyed kids and moms about what they’d like to see on a site about skin, hair and nails.  The top rated response for the kids was games (86 percent) but they also wanted information about:

·         what to do if your nail gets hurt or bruised (60 percent)

·         what makes hair grow (54 percent) and

·         information about bug bites (49 percent)

Moms wanted to know that the site is run by a respected health organization (92 percent), for their kids to learn proper hygiene for skin, hair and nails (49 percent) and to have an area where they could interact with their child while learning about health issues (39 percent). It’s all there on KidsSkinHealth.org.

The Academy solely developed the Web site’s content.  The following industry supporters helped underwrite the cost of the Web site’s creation:  Beiersdorf, Inc., Dermik Laboratories, a business of sanofi-aventis U.S. LLC, Galderma Laboratories, L.P., Graceway Pharmaceuticals, LLC, Intendis, Inc., Merz Pharmaceuticals, LLC, Ortho Dermatologics, PharmaDerm, a division of Nycomed US, Inc., Procter & Gamble, and Stiefel Laboratories, Inc.

About American Academy of Dermatology

Headquartered in Schaumburg, Ill., the American Academy of Dermatology (Academy), founded in 1938, is the largest, most influential, and most representative of all dermatologic associations. With a membership of more than 16,000 physicians worldwide, the Academy is committed to: advancing the diagnosis and medical, surgical and cosmetic treatment of the skin, hair and nails; advocating high standards in clinical practice, education, and research in dermatology; and supporting and enhancing patient care for a lifetime of healthier skin, hair and nails. For more information, contact the Academy at 1-888-462-DERM (3376) or www.aad.org

]]>tag:aad.org,2009-00-02:news/releases/Dermatologists_Launch_New_Web_Site_and_Game_to_Tea2009-11-02T09:17:54-08:00Samantha Sheridan Named Director of Science and Quality of The American Academy of Dermatology2009-10-27T12:00:00-08:00The American Academy of Dermatology (AAD) recently welcomed Samantha Sheridan as the director of science and quality. In her new role, Sheridan will oversee the activities under the purview of the Council on Science and Research, as well as the Patient Safety and Quality Committee, including guidelines and performance measure development, informatics, survey research, and data collection.

“Samantha is a wonderful addition to the Academy staff as director of science and quality,” said Executive Director and CEO Ronald A. Henrichs, CAE. “Her knowledge and experience will be invaluable in helping dermatologists develop and disseminate practice guidelines and other tools to facilitate the delivery of quality dermatologic care.”

Sheridan comes to the Academy after 19 years with Westat, a large contract research organization that has done extensive work with government agencies, including the Agency for Healthcare Research and Quality (AHRQ), the Centers for Medicare and Medicaid Services (CMS), and the Departments of Defense and Veterans Affairs. During her time at Westat, Sheridan oversaw AHRQ’s suite of patient experience surveys for facility and ambulatory care, known as the Consumer Assessment of Healthcare Providers and Systems, or CAHPS, as well as projects for the American College of Surgeons and the American Board of Medical Specialties. Sheridan also has experience with convening expert panels and conferences, helping her to establish a wide range of contacts with various stakeholders in the health care quality community.


Sheridan earned both a Bachelor of Arts and Master of Arts in political science from Villanova University and is a certified Project Management Professional.


Headquartered in Schaumburg, Ill., the American Academy of Dermatology (Academy), founded in 1938, is the largest, most influential, and most representative of all dermatologic associations. With a membership of more than 16,000 physicians worldwide, the Academy is committed to: advancing the diagnosis and medical, surgical and cosmetic treatment of the skin, hair and nails; advocating high standards in clinical practice, education, and research in dermatology; and supporting and enhancing patient care for a lifetime of healthier skin, hair and nails. For more information, contact the Academy at 1-888-462-DERM (3376) or www.aad.org.

]]>tag:aad.org,2009-00-27:news/releases/Samantha_Sheridan_Named_Director_of_Science_and_Qu2009-10-27T02:33:21-08:00American Academy of Dermatology Issues New Guidelines for the Management of Psoriasis With Ultraviolet Light Therapy2009-10-22T12:00:00-08:00
Published online in the Journal of the American Academy of Dermatology, this is the Academy’s fifth of six sections of the guidelines of care for psoriasis, with four previously published sections focusing on general recommendations for the treatment of psoriasis and psoriatic arthritis, as well as the use of biologics, topical and systemic therapies.

“Although treatment options for psoriasis have expanded considerably in recent years, UV light therapy remains an important treatment option for many psoriasis patients,” said dermatologist David M. Pariser, MD, FAAD, president of the Academy. “Over the years, phototherapy has been shown to effectively clear psoriasis, and it is a cost-effective therapy that generally does not suppress the body’s immune response like traditional and biologic systemic therapies. However, because this therapy delivers UV light to the skin (a known carcinogen), patients need to be closely monitored by their dermatologists for the potential risk of skin cancer.”

Psoriasis is a chronic skin condition that usually develops before age 35 and is characterized by thick, red, scaly patches that itch and bleed. Nearly 7 million Americans are living with this skin condition. Both genetic and environmental factors contribute to causing the disease. Research has determined that psoriasis is linked to multiple genes, but it is not completely understood how it is inherited. However, there are at least nine locations on different chromosomes that are associated with psoriasis but researchers have not identified the specific genes that are linked to the genetic transmission of the disease.

Types of UVB Therapy
One type of phototherapy that has been used successfully to treat psoriasis for more than 75 years is broadband (BB)-UVB therapy. As its name implies, BB-UVB is used to treat a large area of psoriasis by exposing the affected skin to a specific wavelength of UVB light.

A newer form of UVB therapy introduced in the United States in the 1990s that is commonly used to treat psoriasis is narrowband (NB)-UVB therapy. With this therapy, narrower bands of UVB wavelengths are administered to the affected skin, and studies have shown NB-UVB therapy to be more effective in clearing psoriasis than BB-UVB.

“Studies have shown that psoriasis patients treated with NB-UVB therapy had better results than those treated with BB-UVB, including more rapid clearing and better remission rates,” said Dr. Pariser. “While both therapies are generally well-tolerated, patients must be educated as to the potential long-term side effects of UVB – including an increased risk of skin cancer and premature aging – and protect their eyes by using goggles to decrease the risk of UVB-related cataracts that could form from prolonged exposure.”

Other minor side effects of BB-UVB therapy include redness, itching, burning and stinging. Burning also is a possible side effect of NB-UVB, and Dr. Pariser noted that, although not commonly reported, there have been instances of skin blistering after exposure to NB-UVB. In addition, neither BB-UVB nor NB-UVB therapy are known to cause birth defects or disrupt a pregnancy and can be prescribed to women during pregnancy or while attempting to conceive.

Studies examining the use of and long-term safety of UVB therapy in children are limited, but Dr. Pariser explained that this therapy could be considered as a second option in selected children whose psoriasis does not respond to topical therapy as long as the light therapy is closely monitored by a dermatologist.

In some cases, UVB therapy is effective when used by itself to clear psoriasis, but dermatologists commonly use this therapy in combination with topical or systemic medications. Dr. Pariser emphasized that the decision to use combination therapy should be made on a case-by-case basis and should be tailored to meet individual patients’ needs.

PUVA Photochemotherapy
“PUVA” is a term applied to a group of therapeutic techniques that use psoralens – a group of photosensitizing compounds – to sensitize cells to the effects of UVA light. Psoralens are available as oral or topical medications that patients must use before being exposed to UVA light, or in a bath formula that patients soak in prior to UVA exposure (this form of PUVA is not as widely used). Two large, multicenter studies have demonstrated the efficacy of PUVA in the treatment of psoriasis, and Dr. Pariser noted that PUVA treatment often leads to the clearing of psoriasis typically within 24 treatments with remissions lasting between three and six months.

“The introduction of PUVA for the treatment of psoriasis was a major advance for patients with severe psoriasis, as it offered them an outpatient therapy rather than other treatments that required hospitalization,” said Dr. Pariser. “However, studies show that high cumulative exposure to oral PUVA is associated with an increase in the risk of non-melanoma skin cancer, particularly squamous cell carcinoma, which is why dermatologists often reserve PUVA for psoriasis patients who have not responded favorably to other treatments.”

In an effort to minimize the total dosage of PUVA, dermatologists often combine PUVA treatments with other therapies (such as retinoids) or in rotation with other treatments. In addition to the increased risk of skin cancer and skin aging with long-term use, other common side effects of PUVA include redness, itching, dryness, irregular pigmentation, nausea and vomiting. PUVA also is not recommended for use in children or in patients with certain medical conditions, which is why dermatologists closely evaluate patients before PUVA is considered as a treatment option for psoriasis.

Targeted Phototherapy (Excimer Laser)
With the introduction of the 308 nm monochromatic xenon-chloride laser for psoriasis in 1997, the use of phototherapy to treat localized lesions became more practical and more widely available. Excimer lasers selectively target affected lesions without treating unaffected skin – therefore minimizing the potential risk of exposing uninvolved skin to UV radiation. Another advantage is that because only the affected areas are treated, higher doses can be administered in fewer treatment sessions.

Although numerous studies have demonstrated that treatment with the excimer laser can clear psoriasis, there is limited information about the duration of remission and the recommended dosage and scheduling of therapy. Dr. Pariser explained that most patients experience long-term improvement following treatment with the excimer laser, and currently the dose of energy delivered is guided by the patients’ skin type and thickness of the psoriasis plaques.

“Typically, patients receive treatment with the excimer laser two to three times a week, with a minimum of 48 hours between treatments,” said Dr. Pariser. “Side effects are minimal and are limited to the treatment area, with redness, burning and darkening of the skin being the most common. There have been cases where blistering has occurred with the use of higher doses of energy, but for the most part treatments are well-tolerated – even in children.”

Patient Considerations for UV Light Therapy
Like all treatments for psoriasis, some patients make better candidates for UV light therapy than others. Dr. Pariser added that before UV light therapy is considered, all patients must have a complete history and physical examination and be made aware of the potential long-term risks of this treatment.

“Patients with a known history of lupus (a chronic inflammatory disease) or xeroderma pigmentosum (a genetic disease characterized by extraordinary sensitivity to sunlight) should not be treated with phototherapy,” said Dr. Pariser. “In addition, patients with atypical nevi, multiple non-melanoma skin cancers, multiple risk factors for melanoma, a history of melanoma, a history of photosensitivity disorder, or who are taking photosensitizing medications or are immunosuppressed as a result of organ transplantation should be screened carefully before starting UV light therapy.”

Recommended dosing guidelines for both BB-UVB and NB-UVB vary by skin type, with light-skinned patients receiving much smaller initial and incremental doses of UV light than darker-skinned patients.

“For the right patients and with close monitoring by a dermatologist, UV light therapy can be a safe and effective treatment for psoriasis patients who might not have responded well to other traditional therapies or for various reasons might not be good candidates for systemic medications,” said Dr. Pariser. “Dermatologists can recommend the best treatment plan for patients with mild to severe psoriasis, helping them improve their condition and overall quality of life.”

To learn more about psoriasis, visit www.skincarephysicians.com/PsoriasisNet, a Web site developed by dermatologists that provides patients with up-to-date information about the treatment and management of disorders of the skin, hair and nails.

Headquartered in Schaumburg, Ill., the American Academy of Dermatology (Academy), founded in 1938, is the largest, most influential, and most representative of all dermatologic associations. With a membership of more than 16,000 physicians worldwide, the Academy is committed to: advancing the diagnosis and medical, surgical and cosmetic treatment of the skin, hair and nails; advocating high standards in clinical practice, education, and research in dermatology; and supporting and enhancing patient care for a lifetime of healthier skin, hair and nails. For more information, contact the Academy at 1-888-462-DERM (3376) or visit www.aad.org.

Editor’s Note: A copy of the guidelines can be accessed through the Academy’s Web site at www.aad.org/research/PsoriasisGuidelines.htm.

Jennifer Allyn                       Kara McFarland                        Allison Sit
(847) 240-1730                     (847) 240-1701                         (847) 240-1746
jallyn@aad.org                  kmcfarland@aad.org              asit@aad.org
]]>tag:aad.org,2009-00-22:news/releases/American_Academy_of_Dermatology_Issues_New_Guideli42009-10-26T02:15:07-08:00Health Alert: Dermatologists Warn Farmers to Pay Special Attention to Suspicious Moles2009-10-06T12:00:00-08:00
“More than 11,000 Americans die each year from skin cancer, but when detected early, skin cancer has a cure rate of 99 percent,” said dermatologist David M. Pariser, MD, FAAD, president of the American Academy of Dermatology. “Since research shows farmers are among the least likely workers to receive a skin examination by a physician, it’s important that farmers perform regular skin self-examinations, which could mean the difference between life and death.”

Performing a skin self-examination consists of regularly looking over the entire body, including the back, scalp, soles of the feet, between the toes and on the palms of the hands. To do a thorough exam, it is important to use both full-length and hand-held mirrors, so it is possible to see the back of the head, back and buttocks.

People are advised to use the ABCDEs of Melanoma Detection to determine if a mole or skin lesion should be brought to the attention of a dermatologist. Characteristics of moles for which individuals should check their skin are: Asymmetry (one half unlike the other half), Border (irregular, scalloped or poorly defined), Color (varies from one area to another; shades of tan and brown, black; sometimes white, red or blue), Diameter (the size of a pencil eraser or larger), and Evolving (changing in size, shape or color). A mole with any of these characteristics, or one that is an “ugly duckling”, meaning it looks different from the rest, should be brought to a dermatologist’s attention.

To assist with skin self-examinations, the Academy has created a free, downloadable Body Mole Map, which provides information on how to perform a skin exam, images of the ABCDEs of melanoma and space for people to track their moles to determine any changes over time. The mole map is available at www.aad.org/checkspot. The Web site also has information about how to find a free skin cancer screening held by a dermatologist in your area.

“Since skin cancer is the only cancer you can see on the surface of your skin, people who check their skin regularly for any suspicious moles are taking an important step in detecting skin cancer in its earliest stages,” said dermatologist David M. Pariser, MD, FAAD, president of the Academy. “Make a skin self-exam more effective by asking a partner to monitor your skin for any changes or to assist in examining hard-to-reach areas.”

To minimize your risk of skin cancer, the Academy recommends that everyone Be Sun SmartSM :
  • Before heading out to the field or pasture, generously apply a broad-spectrum, water-resistant sunscreen with a Sun Protection Factor (SPF) of at least 15 to all exposed skin. The term broad-spectrum means that the sunscreen provides protection from both ultraviolet A (UVA) and ultraviolet B (UVB) rays. Re-apply every two hours, even on cloudy days, and after swimming or sweating.
  • Wear protective clothing, such as a long-sleeved shirt, pants, a wide-brimmed hat and sunglasses, where possible.
  • Seek shade when appropriate, remembering that the sun's rays are strongest between 10 a.m. and 4 p.m. If your shadow is shorter than you are, seek shade. Make sure your tractor has a sun umbrella.
  • Protect children from sun exposure by playing in the shade, using protective clothing, and applying sunscreen.
  • Use extra caution near water, snow and sand as they reflect the damaging rays of the sun which can increase your chance of sunburn.
  • Get vitamin D safely through a healthy diet that may include vitamin supplements. Don't seek the sun.
  • Avoid tanning beds. Ultraviolet light from the sun and tanning beds can cause skin cancer and wrinkling. If you want to look like you've been in the sun, consider using a sunless self-tanning product, but continue to use sunscreen with it.
  • Check your birthday suit after harvest. If you notice anything changing, growing, or bleeding on your skin, see a dermatologist. Skin cancer is very treatable when caught early.
  • Check the Academy’s Web site for the latest list of sun-protective products that meet the stringent criteria of the AAD SEAL OF RECOGNITION®.
    Significantly more than 1 million cases of skin cancer are diagnosed in the United States each year. Current estimates are that 1 in 5 Americans will be diagnosed with skin cancer in their lifetime. One American dies of melanoma almost every hour (every 61 minutes).

For more information about skin cancer, please visit the SkinCancerNet section of www.SkinCarePhysicians.com, a Web site developed by dermatologists that provides patients with up-to-date information on the treatment and management of disorders of the skin, hair and nails.

Headquartered in Schaumburg, Ill., the American Academy of Dermatology (Academy), founded in 1938, is the largest, most influential, and most representative of all dermatologic associations. With a membership of more than 16,000 physicians worldwide, the Academy is committed to: advancing the diagnosis and medical, surgical and cosmetic treatment of the skin, hair and nails; advocating high standards in clinical practice, education, and research in dermatology; and supporting and enhancing patient care for a lifetime of healthier skin, hair and nails. For more information, contact the Academy at 1-888-462-DERM (3376) or www.aad.org. 

]]>tag:aad.org,2009-00-06:news/releases/Health_Alert_Dermatologists_Warn_Farmers_to_Pay_Sp2009-10-12T04:12:56-08:00American Academy of Dermatology Association Commends Howard County for Proposing the Most Restrictive Indoor Tanning Regulation in the Country2009-09-22T12:00:00-08:00
“The American Academy of Dermatology Association applauds Howard County for proposing such a restrictive regulation and urges members of the county’s Board of Health to enact this into law,” said dermatologist David M. Pariser, MD, FAAD, president of the American Academy of Dermatology Association. “This resolution comes on the heels of new research published in the Archives of Dermatology that shows teenagers have alarming access to artificial UV radiation even in states with parental consent and accompaniment restrictions. A ban on indoor tanning for minors is needed to begin to protect our young people from this cancer-causing behavior.”

The United States Department of Health and Human Services and the World Health Organization’s International Agency for Research on Cancer have stated that ultraviolet (UV) radiation from the sun and artificial sources, such as tanning beds and sun lamps, is a known human carcinogen, in the same category as cigarettes. Yet, nearly 30 million people tan indoors in the United States annually. Of these, 2.3 million are teens.

“Just as U.S. law prohibits sales of cigarettes to teenagers, there should be laws that restrict teen use of indoor tanning by those under 18,” said Dr. Pariser.

More than 1 million new cases of skin cancer will be diagnosed in the United States this year. Indoor tanning before the age of 35 has been associated with a 75 percent increase in the risk of melanoma, the deadliest form of skin cancer, which has become more common in females 15-29 years old.

The American Academy of Dermatology (Academy), founded in 1938, is the largest, most influential, and most representative of all dermatologic associations. A sister organization to the Academy, the American Academy of Dermatology Association is the resource for government affairs, health policy and practice information for dermatologists, and plays a major role in formulating socioeconomic policies that can enhance the quality of dermatologic care. With a membership of more than 16,000 physicians worldwide, the Academy is committed to: advancing the diagnosis and medical, surgical, and cosmetic treatment of the skin, hair and nails; advocating high standards in clinical practice, education, and research in dermatology; and supporting and enhancing patient care for a lifetime of healthier skin. For more information, contact the Academy at 1-888-462-DERM (3376) or www.aad.org. ]]>tag:aad.org,2009-00-22:news/releases/American_Academy_of_Dermatology_Association_Commen22009-09-22T02:18:26-08:00Statement from AADA Regarding Archives of Dermatology Study on Teen Tanning Access2009-09-21T12:00:00-08:00This study adds to the mountain of evidence that indoor tanning should be restricted for those under 18. Regardless of the current parental consent and accompaniment restrictions in some states, this study shows young people have alarming access to artificial UV radiation, more than double the FDA’s recommended limit for first-week frequency. 


Artificial UV radiation is a known carcinogen (cancer-causing substance) in the same category as cigarettes, as declared by the U.S. Department of Health & Human Services and the World Health Organization’s (WHO) International Agency for Research on Cancer (IARC). Just as U.S. law prohibits sales of cigarettes to teenagers, there should be laws that prohibit use of indoor tanning by those under 18.
 

Indoor tanning is dangerous for all people, especially young people. Studies have linked artificial UV radiation to a substantially increased risk of developing squamous cell carcinoma, a common type of skin cancer. IARC conducted a review of seven studies and found a 75% increased risk of developing melanoma, the deadliest form of skin cancer, in those who had been exposed to UV radiation from indoor tanning before the age of 35. Melanoma also is the most common form of cancer in young adults 25-29 years old and the second most common cancer in adolescents and young adults 15-29 years old. 

 

Despite all the evidence, only 30 states in the U.S. regulate indoor tanning use by minors, even though the WHO calls for prohibiting minors from indoor tanning because of the danger of developing skin cancer. Estimates show 2.3 million teens still use indoor tanning equipment each year, even though the impact of artificial UV radiation on the skin is well-known. 

 

We are heartened to see that this study shows state and local laws are having some impact.  However, without an outright ban for minors, it’s impossible to begin to protect our young people from this cancer-causing behavior. It’s time to enact legislation to save our children from harm.

 

The American Academy of Dermatology, founded in 1938, is the largest, most influential, and most representative of all dermatologic associations. A sister organization to the Academy, the American Academy of Dermatology Association is the resource for government affairs, health policy and practice information for dermatologists, and plays a major role in formulating policies that can enhance the quality of dermatologic care. With a membership of more than 16,000 physicians worldwide, the Academy is committed to: advancing the diagnosis and medical, surgical, and cosmetic treatment of the skin, hair and nails; advocating high standards in clinical practice, education, and research in dermatology; and supporting and enhancing patient care for a lifetime of healthier skin. For more information, contact the Academy at 1-888-462-DERM (3376) or www.aad.org.

]]>tag:aad.org,2009-00-21:news/releases/Statement_from_AADA_Regarding_Archives_of_Dermatol2009-10-07T05:32:33-08:00Dermatologists Screen More Than 1,300 People for Skin Cancer at Kentucky State Fair2009-09-14T12:00:00-08:00
“With its emphasis on agriculture, the fair provided a great opportunity to reach farmers who are at a high risk of skin cancer due to overexposure from the sun’s ultraviolet (UV) rays,” said dermatologist David M. Pariser, MD, FAAD, president of the American Academy of Dermatology. “Research shows farmers are among the least likely workers to receive a skin examination by a physician, which makes free screenings like this one extremely important.”

Twenty-one dermatologists, led by Timothy S. Brown, MD, FAAD, of Louisville, volunteered 66 hours to screen 1,308 people for skin cancer at the booth located in the Health Horizons exhibit hall. Through the screening, dermatologists detected more than 315 suspicious lesions, including seven suspected melanomas. In addition, the following statistics were gathered:
 
  • 50% had never had their skin checked for cancer by a dermatologist or other doctor in the past.
  • 67% had never been to a skin cancer screening before. 
  • 54% would not have seen a doctor for their skin even without this screening. 
  • 77% do not have a regular dermatologist.

 
Dermatologists have been conducting skin cancer screenings in conjunction with the Kentucky Cancer Program at the Kentucky State Fair for 20 years. The Academy’s national screening program began in 1985 and to date Academy members have conducted more than 1.9 million free skin cancer screenings. More than 188,000 suspicious lesions have been detected, including more than 21,500 suspected melanomas.

Significantly more than 1 million cases of skin cancer are diagnosed in the United States each year. Current estimates are that 1 in 5 Americans will be diagnosed with skin cancer in their lifetime. One American dies of melanoma almost every hour (every 61 minutes).

For more information about skin cancer, please visit the SkinCancerNet section of www.SkinCarePhysicians.com, a Web site developed by dermatologists that provides patients with up-to-date information on the treatment and management of disorders of the skin, hair and nails. Visit www.aad.org to find a free skin cancer screening in your area.

Headquartered in Schaumburg, Ill., the American Academy of Dermatology (Academy), founded in 1938, is the largest, most influential, and most representative of all dermatologic associations. With a membership of more than 16,000 physicians worldwide, the Academy is committed to: advancing the diagnosis and medical, surgical and cosmetic treatment of the skin, hair and nails; advocating high standards in clinical practice, education, and research in dermatology; and supporting and enhancing patient care for a lifetime of healthier skin, hair and nails. For more information, contact the Academy at
1-888-462-DERM (3376) or www.aad.org.

]]>tag:aad.org,2009-00-14:news/releases/Dermatologists_Screen_More_Than_1300_People_for_Sk2009-09-11T08:41:51-08:00Tim Gunn Hosts Addressing Psoriasis™ Fashion Show to Raise Awareness of Psoriasis2009-09-02T12:00:00-08:00Cynthia McGowen of League City, Texas Named Most Inspirational, as Voted by the Public on AddressPsoriasis.com

Today, Tim Gunn, television host and fashion consultant (“Project Runway,” “Tim Gunn’s Guide to Style”) and chief creative officer of Liz Claiborne, Inc., is hosting the Addressing Psoriasis™ Fashion Show, sponsored by Amgen and Wyeth, in New York City. The fashion show recognizes people with moderate to severe plaque psoriasis who have not allowed the condition to inhibit their personal style. Winners of the Addressing Psoriasis™ contest are walking the runway in custom-designed outfits created by emerging talent from the Fashion Institute of Technology (FIT) to help raise public awareness of psoriasis.

“Participating in the Addressing Psoriasis™ campaign and meeting these eight special people has been an honor,” said Gunn. “They are an inspiration to the psoriasis community because they have proven that psoriasis does not need to stand in the way of personal style. I congratulate them all on their efforts to overcome the style challenges that this chronic medical condition can present.”

The Addressing Psoriasis™ Fashion Show is the culmination of an awareness campaign designed to help people with plaque psoriasis get more information about managing their disease and feel more confident in their everyday style. The eight contest winners were selected from among hundreds of entries and were chosen based on the inspirational nature of their story about overcoming the challenges of living with moderate to severe plaque psoriasis and how it has impacted their personal style and the clothing they wear.

Since July, thousands of people from the general public – including those without psoriasis – have cast their votes to select the most inspirational story from among the eight winners. Today, Gunn is announcing that Cynthia McGowen of League City, Texas has been voted the most inspirational.

“Walking the runway in the Addressing Psoriasis™ Fashion Show has been so exciting. I am thrilled my story was voted as the most inspirational, although I truly believe that all of the winners had very inspiring stories to share,” said Cynthia McGowen. “Once I learned more about my condition and how to manage it with the help of my dermatologist, I was able to see style as less of a challenge and more of a fun way to present myself to the world. I hope that others who live with this condition are able to take back their style too.”

The winners’ stories, as well as footage of the Addressing Psoriasis™ Fashion Show will be available on www.addresspsoriasis.com. The Web site also features useful resources about psoriasis – including links to the American Academy of Dermatology, National Psoriasis Foundation and Psoriasis Cure Now – and style tips from Gunn.

Psoriasis, which affects nearly 7 million Americans, is a chronic disease of the immune system that causes the skin cells to grow at an accelerated rate. Although there are several types of psoriasis, approximately 80 percent of psoriasis patients have plaque psoriasis, which causes itchy, red scaly patches which may be painful. People with psoriasis often experience feelings of self-consciousness and choose their clothing because of the appearance of their skin.

About Addressing Psoriasis™
The Addressing Psoriasis™ campaign was developed to inspire people with plaque psoriasis to be confident and not allow the condition to inhibit their everyday style. Addressing Psoriasis™ is sponsored by Amgen and Wyeth with participation from the American Academy of Dermatology, the National Psoriasis Foundation and Psoriasis Cure Now. To learn more about Addressing Psoriasis™ and view Official Rules, visit www.addresspsoriasis.com.

About Amgen and Wyeth
Amgen discovers, develops, manufactures and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives. To learn more about our pioneering science and our vital medicines, visit www.amgen.com.

Wyeth Pharmaceuticals, a division of Wyeth, has leading products in the areas of women’s health care, infectious disease, gastrointestinal health, central nervous system, inflammation, transplantation, hemophilia, oncology, vaccines and nutritional products.

Wyeth is one of the world’s largest research-driven pharmaceutical and health care products companies. It is a leader in the discovery, development, manufacturing and marketing of pharmaceuticals, vaccines, biotechnology products and non-prescription medicines that improve the quality of life for people worldwide. The Company’s major divisions include Wyeth Pharmaceuticals, Wyeth Consumer Healthcare and Fort Dodge Animal Health. To learn more, visit www.wyeth.com.

About American Academy of Dermatology
Headquartered in Schaumburg, Ill., the American Academy of Dermatology (Academy), founded in 1938, is the largest, most influential, and most representative of all dermatologic associations. With a membership of more than 16,000 physicians worldwide, the Academy is committed to: advancing the diagnosis and medical, surgical and cosmetic treatment of the skin, hair and nails; advocating high standards in clinical practice, education, and research in dermatology; and supporting and enhancing patient care for a lifetime of healthier skin, hair and nails. For more information, contact the Academy at 1-888-462-DERM (3376) or http://www.aad.org.

About National Psoriasis Foundation
The National Psoriasis Foundation is the world's largest nonprofit patient advocacy organization and the voice for millions of Americans who are affected by psoriasis and psoriatic arthritis. Our mission is to find a cure for psoriasis and psoriatic arthritis and to eliminate their devastating effects through research, advocacy and education. For more information, call the Psoriasis Foundation at 800-723-9166, or visit www.psoriasis.org.

About Psoriasis Cure Now
Psoriasis Cure Now is a nonprofit organization fueled by a nationwide network of volunteers. Our focus is on accelerating the search for a cure by mobilizing people in support of increased research funding for psoriasis and psoriatic arthritis. We also work to educate psoriasis patients about their treatment options and the public about the seriousness of psoriasis. http://www.psoriasis-cure-now.org.

About the Fashion Institute of Technology
The Fashion Institute of Technology is a college of art and design, business and technology of the State University of New York with more than 40 majors, including Fashion Design. The Fashion Design degree program at FIT prepares students to excel and flourish in the fashion industry. The program’s philosophy focuses on individual student development with an emphasis on professionalism. The learning environment broadens students’ aesthetics, critical thinking and problem-solving skills. FIT’s Fashion Design program leads to the Associate of Applied Sciences and Bachelor of Fine Arts degrees. http://www.fitnyc.edu/html/dynamic.html.
]]>tag:aad.org,2009-00-02:news/releases/Tim_Gunn_Hosts_Addressing_Psoriasis_Fashion_Show_t2009-09-04T08:08:28-08:00Quick Check That Could Save Your Grandparents’ Lives2009-09-01T12:00:00-08:00
Based on current estimates, substantially more than 1 million new cases of skin cancer are diagnosed in the United States every year. Melanoma, the deadliest form of skin cancer, is being diagnosed more rapidly in men age 65 and older than in the general population. A history of exposure to UV rays is a risk factor for skin cancer.

The Academy has created several tools to make it easy to determine if a mole is suspicious and should be brought to a dermatologist’s attention. The Academy’s Body Mole Map is a tool individuals can use to track their moles. The map provides information on how to perform a skin exam, images of the ABCDEs of melanoma and space for people to track their moles to determine any changes over time. The mole map is downloadable at no cost at www.aad.org/checkspot. 

“Performing these checks regularly can help determine if a mole seems to be changing, which could be a sign of skin cancer,” said dermatologist David M. Pariser, MD, FAAD, president of the Academy. “Early detection is a key factor in the fight against skin cancer and ultimately can help save lives.”
 
One American dies of melanoma every hour (every 61 minutes). The five-year survival rate for people whose melanoma is detected and treated before it spreads to the lymph nodes is 99 percent. For more information about skin cancer, please visit the SkinCancerNet section of www.skincarephysicians.com, a Web site developed by dermatologists that provides patients with up-to-date information on the treatment and management of disorders of the skin, hair and nails.

Headquartered in Schaumburg, Ill., the American Academy of Dermatology (Academy), founded in 1938, is the largest, most influential, and most representative of all dermatologic associations. With a membership of more than 16,000 physicians worldwide, the Academy is committed to: advancing the diagnosis and medical, surgical and cosmetic treatment of the skin, hair and nails; advocating high standards in clinical practice, education, and research in dermatology; and supporting and enhancing patient care for a lifetime of healthier skin, hair and nails. For more information, contact the Academy at 1-888-462-DERM (3376) or www.aad.org. ]]>tag:aad.org,2009-00-01:news/releases/Quick_Check_That_Could_Save_Your_Grandparents_Live2009-09-01T04:06:32-08:00Making the Outdoors Safer for Communities: The American Academy of Dermatology Announces 2009 AAD Shade Structure Program Grant Recipients2009-08-13T12:00:00-08:00  
Today the Academy announced the recipients of the 2009 AAD Shade Structure Program grants.

“The Academy is pleased to award grants to these organizations which have outdoor areas in need of shade and that have demonstrated a commitment to sun safety,” said dermatologist David M. Pariser, MD, FAAD, president of the Academy. “Combined, these 34 shade structures will be used by more than 16,687 individuals every day. The Academy is proud to work with these organizations to reinforce the importance of protecting the skin when outdoors.”

The recipients of the 2009 AAD Shade Structure Program grants are:
  1. Amelia Earhart Elementary, Goddard, Kansas, sponsored by Steven M. Passman, MD, FAAD
  2. Anthony Wayne Rehabilitation Center for Handicapped and Blind, Inc., Fort Wayne, Ind., sponsored by Jennifer L. Hobbs, MD, FAAD
  3. Bay View Elementary School, Monterey, Calif., sponsored by Joseph R. Rheim, MD, FAAD
  4. Bear Exploration Center, Montgomery, Ala., sponsored by John L. Anthony MD, FAAD
  5. Buncombe County Schools Foundation, Inc., Asheville, N.C., sponsored by Daniel J. Smith, MD, FAAD
  6. C.E. Boger Elementary School PTO, Kannapolis, N.C., sponsored by William D. Hoover, Jr., MD, FAAD
  7. Cherry Hill Education Foundation, Cherry Hill, N.J., sponsored by Emily Miller, MD, FAAD
  8. Child Care Resources, Zanesville, Ohio, sponsored by John P. Hibler, DO, FAAD
  9. Columbia Elementary School, Palm Bay, Fla., sponsored by Joseph J. Chanda, MD, FAAD
  10. Community Action of Northeast Indiana Head Start, Fort Wayne, Ind., sponsored by Thomas W. McGovern, MD, FAAD
  11. Community Services for Children, Inc., Allentown, Pa., sponsored by J. Greg Brady, DO, FAAD
  12. Copper Hill Elementary School, Ringoes, N.J., sponsored by Christopher T. Cassetty, MD, FAAD
  13. Cottonwood Elementary School, Tucson, Ariz., sponsored by John C. Moseley, MD, FAAD
  14. DuBois Area Catholic School, DuBois, Pa., sponsored by Richard Johnson, DO
  15. Ed Cody Elementary, San Antonio, Texas, sponsored by Scott M. Henslee, MD, FAAD
  16. The Family Y, Augusta, Ga., sponsored by Sanders R. Callaway, MD, FAAD
  17. Friends of West Tennessee School for the Deaf, Jackson, Tenn., sponsored by William P. Teer, MD, FAAD
  18. Girl Scouts – Dakota Horizons, Sioux Falls, S.D., sponsored by Sarah K. Sarbacker, MD, FAAD
  19. Girl Scouts Heart of the Hudson/Woodbury Parks & Recreation Department, Highland Mills, N.Y., sponsored by Joseph G. Tuchman, MD, FAAD and Steven Wolinsky, MD, FAAD
  20. Girls Inc. of Jackson County, Seymour, Ind., sponsored by Kevin M. Crawford, MD, FAAD
  21. Grahamwood Elementary School, Memphis, Tenn., sponsored by Riddell W. Scott, MD, FAAD
  22. Hillrise Elementary, Las Cruces, N.M., sponsored by Robert J. Segal, MD, FAAD
  23. LaRue Miller Elementary School, Midlothian, Texas, sponsored by Cathleen P. Bateman, MD, FAAD
  24. Leominster Education Foundation for Samoset Preschool, Leominster, Mass., sponsored by Thomas H. Cahn, MD, FAAD
  25. Los Angeles Parks Foundations, Los Angeles, Calif., sponsored by Mary Lee Amerian, MD, FAAD
  26. Lt. Joseph P. Kennedy Institute, Washington, D.C., sponsored by Maria L. Turner, MD, FAAD
  27. Maryland Avenue Elementary School PTA, La Mesa, Calif., sponsored by Erik O. Gilbertson, MD, FAAD
  28. Meeting Street, Providence, R.I., sponsored by Charles J. McDonald, MD, FAAD
  29. Outdoor Discovery Center of Wildlife Unlimited, Holland, Mich., sponsored by Mary Yurko, MD, PhD, FAAD,
  30. Waccamaw Intermediate School PTO, Pawleys Island, S.C., sponsored by Carl E. Weimer, Jr., MD, FAAD
  31. Wallace A. Smith Elementary, Ooltewah, Tenn., sponsored by Jeff J. Ligon, MD, FAAD
  32. Wewahitchka Elementary School, Wewahitchka, Fla., sponsored by Charles R. Kovaleski, MD, FAAD
  33. Young Families Early Head Start, Inc., Billings, M.T., sponsored by Roberta J. Hawk, MD, FAAD
  34. Water Conservation Garden, El Cajon, Calif., sponsored by Doyle D. Hansen, MD, FAAD and Michael J. Thoene, MD, FAAD

This is the ninth year that the Academy has offered its Shade Structure Program in which Academy members play an integral role by encouraging local organizations to apply for the grants and by writing letters of support, a requirement for consideration of applications. The program is open to non-profit organizations or educational institutions serving children and teens under the age of 18, for permanent shade structures over outdoor locations which are not protected from the sun, such as playgrounds, pools, eating areas and other locations. The Academy receives support for this program from Johnson & Johnson Consumer Products Company.

Since 2002 the Academy has awarded 174 shade structure grants to organizations across the country. These shade structures provide shade for more than 125,314 individuals.

“This program furthers the Academy’s commitment to reducing the incidence of skin cancer by increasing the amount of shade available and encouraging individuals and communities to incorporate sun safety into their daily outdoor activities,” said Dr. Pariser.

This year, more than 1 million new cases of skin cancer will be diagnosed in the United States. It is estimated that there will be about 121,840 new cases of melanoma (the deadliest form of skin cancer) in 2009.

For more information about skin cancer, please visit www.skincarephysicians.com, a Web site developed by dermatologists that provides patients with up-to-date information on the treatment and management of disorders of the skin, hair and nails, and click on “SkinCancerNet.”

Headquartered in Schaumburg, Ill., the American Academy of Dermatology (Academy), founded in 1938, is the largest, most influential, and most representative of all dermatologic associations. With a membership of more than 16,000 physicians worldwide, the Academy is committed to: advancing the diagnosis and medical, surgical and cosmetic treatment of the skin, hair and nails; advocating high standards in clinical practice, education, and research in dermatology; and supporting and enhancing patient care for a lifetime of healthier skin, hair and nails. For more information, contact the Academy at 1-888-462-DERM (3376) or www.aad.org.

]]>tag:aad.org,2009-00-13:news/releases/Making_the_Outdoors_Safer_for_Communities_The_Amer12009-08-13T08:39:38-08:00American Academy of Dermatology Commends Reclassification of Tanning Beds as Carcinogenic2009-07-30T12:00:00-08:00
"The American Academy of Dermatology applauds the IARC and the World Health Organization for confirming what the Academy has known for many years – that ultraviolet light is the primary cause of skin cancer and avoiding excessive exposure to the sun and other forms of ultraviolet radiation, such as indoor tanning, is the solution,” said dermatologist David M. Pariser, MD, FAAD, president of the American Academy of Dermatology.

The review concluded that the risk of melanoma, the most deadly form of skin cancer, increases by 75 percent when use of tanning beds and sunlamps begins before 30 years of age. This high-risk tanning behavior, seen primarily in females, could explain the increasing melanoma rates for females 15-29 years old. Since 1992, melanoma has increased 3.1 percent annually in male and female Caucasians, but in recent years it is increasing more rapidly in young Caucasian women (3.8 percent since 1995).

"Indoor tanning is particularly troubling because it is unnecessary and is practiced mainly for cosmetic reasons. Individuals, particularly young people, who utilize tanning beds are intentionally putting their health at risk,” stated Dr. Pariser. “We hope that this new classification will persuade individuals to stop using or avoid indoor tanning all together."

This year, more than 1 million new cases of skin cancer will be diagnosed in the United States — exceeding the incidence of all other cancers combined. It is estimated that there will be about 121,840 new cases of melanoma in 2009. Melanoma is the most common form of cancer for young adults 25-29 years old and the second most common form of cancer for adolescents and young adults 15-29 years old.

Previously, the Academy supported the WHO’s 2005 recommendation that no person under the age of 18 should use a tanning bed. Nearly 30 million people tan indoors in the United States annually and of these, 2.3 million are teens.

The Academy recently lauded the state of Texas for being the first in the nation to prohibit the use of indoor tanning devices for all children and adolescents under the age of 16.5 – the most restrictive law in the country.

The American Academy of Dermatology Association (AADA) position statement on indoor tanning opposes indoor tanning and supports a ban on the production and sale of indoor tanning equipment for non-medical purposes. Additionally, the AADA urges the Food and Drug Administration (FDA) to take action that will ban the sale and use of tanning equipment for non-medical purposes. Unless and until the FDA bans the sale and use of tanning equipment for non-medical purposes, the AADA supports the following requirements for indoor tanning facilities:

  • No minor should be permitted to use tanning devices.
  • A Surgeon General's warning should be placed on all tanning devices. 
  • No person or facility should advertise the use of any ultraviolet A or ultraviolet B tanning device using wording such as "safe," "safe tanning," "no harmful rays," "no adverse effect," or similar wording or concepts.

The American Academy of Dermatology (Academy), founded in 1938, is the largest, most influential, and most representative of all dermatologic associations. A sister organization to the Academy, the American Academy of Dermatology Association is the resource for government affairs, health policy and practice information for dermatologists, and plays a major role in formulating socioeconomic policies that can enhance the quality of dermatologic care. With a membership of more than 16,000 physicians worldwide, the Academy is committed to: advancing the diagnosis and medical, surgical, and cosmetic treatment of the skin, hair and nails; advocating high standards in clinical practice, education, and research in dermatology; and supporting and enhancing patient care for a lifetime of healthier skin. For more information, contact the Academy at 1-888-462-DERM (3376) or www.aad.org.

]]>tag:aad.org,2009-00-30:news/releases/American_Academy_of_Dermatology_Commends_Reclassif2009-07-30T08:41:26-08:00Estrogen Getting Cool Reception From Dermatologists for Mixed Results in Improving Appearance of Skin2009-07-29T12:00:00-08:00
At the American Academy of Dermatology’s Summer Academy Meeting 2009 in Boston, dermatologist Margaret E. Parsons, MD, FAAD, assistant clinical professor of dermatology at the University of California at Davis in Sacramento, reviewed studies that demonstrate mixed results when examining whether or not estrogen improves the appearance of the skin and why patients should opt for tried-and-true cosmetic therapies instead.

“Based on the research conducted thus far, it does not appear that topical or oral estrogens are a viable long-term solution for improving sun-damaged or aging skin,” said Dr. Parsons. “In my practice, I do not prescribe estrogens for skin rejuvenation because of the lack of consistent data to support their use and the known risks of prolonged estrogen therapy – including an increased risk of breast cancer.”

Estrogens are a group of hormones that play a key role in regulating many aspects of a woman’s overall health, including reproduction. Certain parts of the body contain cells that are more receptive to the effects of estrogen than others, including the face. Dr. Parsons noted that estrogens benefit the skin in many ways, including an increase in collagen content, water retention and elasticity. During pregnancy when estrogen levels are at their highest, women experience thicker hair and glowing skin. On the other hand, post-menopausal women may notice that their skin does not have the same elasticity as it once did and that it is drier than normal.

In order to treat the most common symptoms associated with menopause – including hot flashes, mood swings and vaginal changes – physicians often prescribe hormone replacement therapy (HRT) to boost the body’s estrogen levels that drop dramatically during this change of life. However, when the results of the Women’s Health Initiative (WHI) study were announced in 2002, the way HRT was viewed to treat post-menopausal women changed significantly. For example, the WHI study found that women on long-term HRT could be at an increased risk for breast cancer and that the overall health risks of this therapy could outweigh the possible benefits. From that point on, HRT was prescribed more conservatively with lower dosing options and individualization based on each woman’s own health history.

Since there were reports of some women on HRT noticing an improvement in their skin, studies were conducted to determine if these results could be validated. Dr. Parsons explained that results of multiple studies examining the relationship between estrogens and skin improvement were inconclusive.

For example, one study examined whether low-dose hormone therapy improved aging skin in 485 women who were on average five years post-menopausal. Published in the September 2008 issue of the Journal of the American Academy of Dermatology1, the study concluded that estrogen supplementation did not provide any significant improvement in sun-damaged skin.

“Although this study found no obvious skin benefits in this particular group of women, another study that looked at women who began HRT at the onset of menopause – and did not wait to start treatment like the other group – did experience noticeable improvements in their skin,” said Dr. Parsons. “These studies pose unanswered questions as to the timing and duration of prescribing HRT to produce skin benefits. For this reason, the jury is still out as to whether estrogens can be effective for aging skin.”

In addition, another study showed that applying topical estrogen to sun-damaged facial skin and sun-protected skin on the hip of post-menopausal women resulted in stimulated collagen production and less wrinkling in the sun- protected hip skin, but no noticeable improvement in the sun-damaged facial skin.

Dr. Parsons added that more research will likely continue in the future to examine the possible benefits of estrogen for improving aging skin. Until then, she stressed that there are many effective therapies that dermatologists regularly use to address the common signs of aging – including retinoids, alpha-hydroxy acids and other topical therapies, as well as chemical peels, lasers, botulinum toxin and skin fillers, to name a few.

“The best advice I can offer my patients to improve their overall skin health is to wear sunscreen with a sun protection factor (SPF) of at least 30, don’t smoke and use a topical retinoid,” said Dr. Parsons. “When it comes to minimizing the cumulative effects of sun damage, an ounce of prevention really does go a long way.”

For more information on improving the appearance of your skin, go to the “AgingSkinNet” section of www.skincarephysicians.com, a Web site developed by dermatologists that provides patients with up-to-date information on the treatment and management of disorders of the skin, hair and nails.

Headquartered in Schaumburg, Ill., the American Academy of Dermatology (Academy), founded in 1938, is the largest, most influential, and most representative of all dermatologic associations. With a membership of more than 16,000 physicians worldwide, the Academy is committed to: advancing the diagnosis and medical, surgical and cosmetic treatment of the skin, hair and nails; advocating high standards in clinical practice, education, and research in dermatology; and supporting and enhancing patient care for a lifetime of healthier skin, hair and nails. For more information, contact the Academy at 1-888-462-DERM (3376) or www.aad.org.

1 Phillips TJ Symons J Menon S et al Does hormone therapy improve age-related skin changes in postmenopausal women? A randomized, double-blind, double-dummy, placebo-controlled multicenter study assessing the effects of norethindrone acetate and ethinyl estradiol in the improvement of mild to moderate age-related skin changes in postmenopausal women. Journal of the American Academy of Dermatology 2008; 59: 397-404. ]]>tag:aad.org,2009-00-29:news/releases/Estrogen_Getting_Cool_Reception_From_Dermatologist2009-07-29T12:56:46-08:00Alternative Therapies for Fighting Eczema Hold Promise, But Dermatologists Caution They Are No Substitute for Proven Medical Treatments2009-07-29T12:00:00-08:00
At the American Academy of Dermatology’s Summer Academy Meeting 2009 in Boston, dermatologist Peter A. Lio, MD, FAAD, assistant professor of dermatology and pediatrics at Northwestern University Feinberg School of Medicine in Chicago, discussed why eczema patients try alternative therapies and how certain therapies used in conjunction with clinically tested medical treatments could hold promise in further improving the condition.

“Part of the difficulty in understanding why people seek alternative medicine lies in defining this term,” said Dr. Lio. “Broadly speaking, it encompasses treatments such as acupuncture, homeopathy and holistic medicine outside of the form of medicine taught in most U.S. medical schools. But people use the term for anything from chicken soup to any lotion or potion sold on the Internet to a new dietary supplement. Unfortunately, a great deal of snake oil can hide under the umbrella of alternative medicine.”

Dr. Lio believes there are two main reasons that patients try alternative therapies for eczema. The first reason is that since the cause of eczema is fully understood nor why it occurs in some people and not others, treatments are based on controlling the symptoms rather than fixing the root cause. Secondly, an increasing number of patients are looking for natural non-medical therapies that do not pose the known side effects of some of the traditional medications. However, many non-medical therapies, especially herbal treatments, marketed for treating eczema are not governed by the U.S. Food and Drug Administration (FDA) or any agency, and contaminants could cause health problems or drug interactions could occur when used with other medications.

“The biggest risk posed by alternative medicines is worsening symptoms due to delayed treatment. In my practice, most of my patients have used some form of alternative therapy, but largely with little or no measurable improvement,” said Dr. Lio. “In fact, one large-scale study found more than half of the eczema patients participating reported using one or more forms of alternative medicine for their disease. The study concluded that the majority of patients reported no improvement or even worsening of their condition after using these alternative treatments.”

While topical corticosteroids (the mainstay in the treatment of eczema), antibacterial agents, topical calcineurin inhibitors and moisturizers are among the most effective medical treatments dermatologists prescribe to treat eczema, Dr. Lio suggested certain alternative therapies may be beneficial for some patients, perhaps by reducing stress.

For example, studies show that physical or emotional stress can worsen atopic dermatitis, and one study concluded that stress directly slows the healing of the skin barrier – or its protective outer layer. In another study, psychosocial stress and sleep deprivation were found to disrupt skin barrier function in healthy patients.

“It is possible that some forms of alternative medicine, such as hypnosis and acupuncture, may help eczema patients by reducing stress,” said Dr. Lio. “The areas of stress reduction and behavior modification are promising and deserve further exploration as a means to complement traditional medical therapies.”

In his practice, some of Dr. Lio’s patients report improvement in their condition with acupuncture, but there are no scientific studies examining this potential benefit. Currently, Dr. Lio is trying to initiate a study on the effects of acupuncture on eczema patients at his institution to examine why acupuncture reportedly benefits some patients but not others.

“I think it is important for patients to inform their dermatologist if they are using alternative therapies, as some could cause dangerous drug interactions with traditional medicine,” said Dr. Lio. “I always tell my patients that the fact that there are thousands of alternative treatments for eczema suggests that not one of them works really well. But if patients are committed to trying alternative medications, they should consult their dermatologist and not forgo their recommended medical regimen.”

For more information on atopic dermatitis, go to the EczemaNet section of www.skincarephysicians.com, a Web site developed by dermatologists that provides patients with up-to-date information on the treatment and management of disorders of the skin, hair and nails.

Headquartered in Schaumburg, Ill., the American Academy of Dermatology (Academy), founded in 1938, is the largest, most influential, and most representative of all dermatologic associations. With a membership of more than 16,000 physicians worldwide, the Academy is committed to: advancing the diagnosis and medical, surgical and cosmetic treatment of the skin, hair and nails; advocating high standards in clinical practice, education, and research in dermatology; and supporting and enhancing patient care for a lifetime of healthier skin, hair and nails. For more information, contact the Academy at 1-888-462-DERM (3376) or www.aad.org. ]]>tag:aad.org,2009-00-29:news/releases/Alternative_Therapies_for_Fighting_Eczema_Hold_Pro2009-07-29T12:57:13-08:00Is Your Hair Taking a Break? Dermatologists Can Help Women Get to the Root of Hair Loss2009-07-29T12:00:00-08:00
At the American Academy of Dermatology’s Summer Academy Meeting 2009 in Boston, dermatologist Amy J. McMichael, MD, FAAD, associate professor of dermatology at Wake Forest University School of Medicine in Winston-Salem, N.C., discussed the different types of hair loss women experience and the current treatment options.

“Hair loss is a very misunderstood condition, both in terms of how people see their own hair loss and how physicians who are not dermatologists approach hair loss,” said Dr. McMichael. “It is important for women to be evaluated by a dermatologist, who specializes in hair loss, at the first signs of a problem – whether she notices that her ponytail is smaller than it used to be, she sees more hair in the shower, or if her part is widening. Determining the cause of the hair loss is the first step in treating it and preventing future hair loss.”

Female-Pattern Hair Loss
The most common form of hair loss in women is female-pattern hair loss, which is a hereditary condition also referred to as androgenetic alopecia. While pattern hair loss affects both men and women, it is very different in women and does not display the classic receding hairline or bald spot on top of the scalp as it does in men. In women, the frontal hairline is usually maintained, but there is visible thinning over the crown. Dr. McMichael explained that in both male- and female-pattern hair loss, the hair stays on the head for a shorter time due to a short growth phase, resulting in baby fine hairs that do not reach their full length or diameter.

Fortunately, several treatment options are effective for women with hair loss. Minoxidil 2% is the only topical medication approved by the U.S. Food and Drug Administration (FDA) for female-pattern hair loss. Minoxidil 5% is only FDA-approved for male-pattern hair loss, but it has been shown to be very effective in women as well. Both the 2% and 5% solutions are available over-the-counter. While minoxidil does not grow new hair, it works by prolonging the growth phase of hair – providing more time for hair to grow out to its full density.

“Minoxidil is a wonderful option for women with thinning hair, as it only treats the hair you want to keep that is not reaching its maximum growth and is an easy way to fill in hair density,” said Dr. McMichael. “Although minoxidil is an over-the-counter treatment, women should consult their dermatologist who is experienced with the product and can explain how it works and off-set any known side effects – such as irritation or fine facial hair that could develop along the cheeks and jaw line.”

In some cases, other medications may be used off-label to treat female hair loss, including finasteride (which is FDA-approved for male-pattern hair loss) for women of non-childbearing age only, and the anti-androgens spironolactone and flutamide that work by blocking the male hormone testosterone at the cellular level of the hair follicle. These oral medications also may be an option for women who may not want to spend time applying minoxidil every day. Dr. McMichael also noted that hair transplantation is an extremely effective procedure for women who want to fully restore their lost hair and works best in conjunction with topical or oral medications to prevent further hair loss.

Telogen Effluvium
Another common form of hair loss in both men and women, telogen effluvium, refers to an increase in the number of hairs in the telogen, or rest, phase of the hair cycle, which typically lasts three months in the normal growth cycle. However, telogen effluvium occurs as a result of the body’s natural physiologic response to some form of stress, causing more hair to enter the rest phase than the normal 10 percent. For example, surgery, childbirth, dramatic weight loss (including gastric bypass surgery), the death of a loved one, starting or stopping oral contraceptives, iron deficiency, and chronic thyroid diseases can trigger this type of hair loss.

“When I evaluate patients’ hair and their recent medical history, I am able to determine if their hair loss is a result of telogen effluvium. I always tell women to be patient and that their hair needs to grow back on its own,” said Dr. McMichael. “In these cases, I would only recommend minoxidil to less than 50 percent of women and oral medications would not be effective. Once the trigger is removed, the hair simply needs to return to normal – which could take anywhere from three to nine months. The key is determining the trigger and when it occurred in relation to the hair loss.”

Alopecia Areata
An autoimmune form of hair loss that can affect men and women, alopecia areata, occurs when the body’s white blood cells attack the hair follicles and put them to sleep. This results in either a small patch of complete hair loss on the scalp that may be easy to cover or complete hair loss on the scalp (similar to the effects of chemotherapy in cancer patients) and/or other areas of the body.

While not as common as other forms of hair loss, this condition can be very psychologically upsetting for women and its manifestations are unpredictable from person to person. For example, alopecia areata can happen overnight or occur gradually over the course of several years. Dr. McMichael noted that typically, alopecia areata is initially seen in children and young adults.

Although there are no FDA-approved treatments for alopecia areata, Dr. McMichael explained that dermatologists may use combination therapies off-label such as injectable steroids, topical steroids or minoxidil 5% to try to regrow hair in patches of bald spots. However, she cautioned that not all patients will experience hair regrowth even with treatment – which could have a significant negative impact on their quality of life.

“Studies examining quality of life issues show that women with hair loss are much more bothered by their condition than men,” said Dr. McMichael. “With men, it has become socially acceptable to be bald, but the same is not true for women. Many of my patients report not going to church because they don’t want people in the pew behind them to see their thinning hair, or they stop exercising because they don’t want to mess up their hair that they’ve spent so much time styling to try to hide their hair loss. It really can affect many aspects of their lives.”

Dr. McMichael is optimistic that research in hair loss will continue to expand in the future. She also suggested that in addition to seeing their dermatologist for proper evaluation and treatment, women who are bothered by their hair loss can find help through the many support groups that are available to patients on the Internet.

Headquartered in Schaumburg, Ill., the American Academy of Dermatology (Academy), founded in 1938, is the largest, most influential, and most representative of all dermatologic associations. With a membership of more than 16,000 physicians worldwide, the Academy is committed to: advancing the diagnosis and medical, surgical and cosmetic treatment of the skin, hair and nails; advocating high standards in clinical practice, education, and research in dermatology; and supporting and enhancing patient care for a lifetime of healthier skin, hair and nails. For more information, contact the Academy at 1-888-462-DERM (3376) or www.aad.org. ]]>tag:aad.org,2009-00-29:news/releases/Is_Your_Hair_Taking_a_Break_Dermatologists_Can_Hel2009-07-29T12:57:33-08:00Hormonal Therapies Offer Effective Solutions for Many Adult Women With Acne2009-07-29T12:00:00-08:001. In fact, after age 20, women are far more likely to report having acne than men. While there is no cure for acne, dermatologists are finding that hormonal therapies can help some women fight bothersome acne that occurs in adulthood.

At the American Academy of Dermatology’s Summer Academy Meeting 2009 in Boston, dermatologist Bethanee J. Schlosser, MD, PhD, FAAD, assistant professor of dermatology and director of the Women’s Skin Health Program at Northwestern University Feinberg School of Medicine in Chicago, discussed the most widely used hormonal therapies available for women with acne and the best candidates for this type of treatment.

Factors that contribute to the formation of acne include excess oil gland production, skin inflammation, abnormal maturation of skin cells lining the hair follicle and an increased number of the acne-causing bacteria Propionibacterium acnes. However, hormones also influence both oil gland production and the maturation of skin cells thereby contributing to the formation of acne lesions. For example, when androgens (the male hormones present in both men and women) over-stimulate the oil glands and hair follicles in the skin, hormonal acne flares can occur.

“Women over the age of 20 may experience worsening of their acne or a change in the nature of their acne. This can include increased lesions on the lower one-third of the face (including the jaw line and upper neck), pre-menstrual flares, and resistance to oral antibiotics and other traditional acne therapies,” said Dr. Schlosser. “For these women, hormonal therapy in the form of combination oral contraceptives and/or anti-androgen medications, such as spironolactone, flutamide and dutasteride that work by reducing the activity of the male hormone testosterone, may provide significant benefit.”

Dr. Schlosser noted that the use of hormonal therapies for acne, including combination oral contraceptives, requires careful screening of patients. For example, there are numerous contraindications (or factors that increase the risks of a particular medication) that must be considered before hormonal therapy is prescribed for treating acne. Such contraindications for combination oral contraceptives include a personal history of breast cancer, heart attack or stroke, uncontrolled high blood pressure, migraines with neurological symptoms, or abnormal vaginal bleeding, to name a few.
Dermatologists will review these factors with patients to determine if hormonal acne therapy poses any potential risks for patients.

Based on a physical examination, a patient’s medical history and the success or failure of previously prescribed acne treatments, dermatologists may recommend hormonal therapy to enhance the results of acne treatment in women. Hormonal therapy in the form of combination oral contraceptive pills has been shown to help treat both inflammatory acne lesions (the papules, pustules and painful nodules under the skin), and non-inflammatory acne lesions (blackheads and whiteheads). Dr. Schlosser suggests that hormonal therapy should not be used in isolation but instead recommends that combination oral contraceptives or anti-androgen medications be used in conjunction with topical retinoids for optimal results.

While there are numerous types of oral contraceptives available that can be used to treat acne in women, three combination oral contraceptive pills have been approved by the U.S. Food and Drug Administration (FDA) for the treatment of acne. All combination oral contraceptives contain an estrogen (ethinyl estradiol for most contraceptive pills) and a progestin. The estrogen component decreases the production of testosterone and other androgens by the ovaries and decreases the amount of active testosterone in the body.

Some progestins may actually mimic the activity of testosterone on the oil gland and thereby worsen acne. Therefore, Dr. Schlosser primarily recommends oral contraceptives that contain one of the following progestins: norgestimate, desogestrel, or drospirenone, all of which demonstrate low or no risk of increasing the activity of the testosterone receptor.

“Combination oral contraceptives can be very beneficial in the treatment of acne in appropriately selected women, and several different oral contraceptives have been shown to be effective in clinical studies,” said Dr. Schlosser. “But the treatment of acne with combination oral contraceptives needs to be targeted to each patient’s individual needs, and patients should be monitored regularly to ensure the safety and effectiveness of their particular therapy.”

Dr. Schlosser cautioned that improvement of acne with hormonal therapy does not occur overnight and requires at least three months of continuous use before a judgment about effectiveness should be made. In many cases, patients need to continue using oral contraceptives to sustain their results over time. However, some patients can stop hormonal therapy and maintain clear skin with the regular use of a topical retinoid.

“For many women with adult-onset acne, combination hormonal therapy can provide excellent results,” added Dr. Schlosser. “Women who think they might be good candidates should discuss their options with their dermatologist who can offer a customized treatment regimen and continual monitoring to ensure optimal results.”

To learn more about acne, visit the AcneNet section of www.skincarephysicians.com, a Web site developed by dermatologists that provides patients with up-to-date information on the treatment and management of disorders of the skin, hair and nails.

Headquartered in Schaumburg, Ill., the American Academy of Dermatology (Academy), founded in 1938, is the largest, most influential, and most representative of all dermatologic associations. With a membership of more than 16,000 physicians worldwide, the Academy is committed to: advancing the diagnosis and medical, surgical and cosmetic treatment of the skin, hair and nails; advocating high standards in clinical practice, education, and research in dermatology; and supporting and enhancing patient care for a lifetime of healthier skin, hair and nails. For more information, contact the Academy at 1-888-462-DERM (3376) or www.aad.org.

1 Collier CN Harper JC Cantrell WC et al The prevalence of acne in adults 20 years and older. Journal of the American Academy of Dermatology 2008; 58 ]]>tag:aad.org,2009-00-29:news/releases/Hormonal_Therapies_Offer_Effective_Solutions_for_M2009-07-29T12:57:57-08:00Consumer Alert: Minimally Invasive Cosmetic Procedures Should Not Be Taken Lightly2009-07-29T12:00:00-08:00
At the American Academy of Dermatology’s Summer Academy Meeting 2009 in Boston, dermatologist C. William Hanke, MD, MPH, FAAD, clinical professor at Indiana University School of Medicine in Indianapolis, offered advice to help patients determine if a cosmetic procedure is right for them, including questions to ask the physician to ensure a safe and effective result or outcome.

“The best advice I can offer consumers is not to be afraid to ask physicians direct questions about their credentials, training, and patient results with any cosmetic procedure,” said Dr. Hanke. “If you are not satisfied with the answers to your questions or if a physician becomes defensive, then these are red flags and you should seek another opinion.”

To help consumers in choosing a qualified physician for a safe and effective cosmetic procedure, Dr. Hanke recommends the following:

  • Look for a physician who specializes in the cosmetic procedure.

Dr. Hanke cautioned that no physician is an expert at every cosmetic procedure. For example, some physicians specialize in laser procedures or liposuction, so Dr. Hanke suggested that consumers look for physicians with particular expertise in the procedure they are considering. Ideally, patients should request to see “before and after” photos of a physician’s actual patients, rather than of another physician’s work.

“To help them learn about the expected outcomes and downtime involved with a procedure, patients should ask their physician if they can speak with a patient who has undergone the procedure,” said Dr. Hanke. “This might help them feel more comfortable about asking questions and to determine if a procedure is right for them.”

The American Academy of Dermatology (Academy) also recommends that consumers ask physicians how many procedures they have performed, what results can be expected, how long the recuperation period is and what are the risks.

  • Consider the highly trained skills of a dermatologist for minimally invasive cosmetic procedures. 

Dr. Hanke explained that most of the minimally invasive cosmetic procedures available today were either developed or refined by dermatologists, such as tumescent liposuction (liposuction using tumescent local anesthesia on awake patients), soft tissue (skin) fillers, and cutaneous laser surgery which includes the removal of tattoos, unwanted hair, and vascular birthmarks, and the treatment of sun-damaged skin.

“Dermatologists specialize in minimally invasive procedures that do not require general anesthesia. This greatly reduces the potential for complications since the patient is awake during the procedure and recovery times are decreased,” said Dr. Hanke. “These procedures offer patients an enhanced version of themselves, and most patients would rather have subtle results than a drastic change, which is indicative of a major procedure.” 

  • Ask who will be performing the procedure.

Dr. Hanke acknowledged that there is inconsistency among physicians as to which cosmetic procedures can be safely and effectively performed by non-physicians. In its official position statement on the use of non-physician clinical personnel that offers guidelines to its members on this practice, the Academy recommends that under appropriate circumstances, a physician may delegate certain procedures and services to appropriately trained non-physicians, such as physician assistants or nurse practitioners. Specifically, the physician must directly supervise the non-physician clinicians to protect the best interests and welfare of each patient.

“Each physician must determine what procedures can safely be performed by nurses or other staff members in his or her own individual practices. This distinction should be made to patients up front to ensure they are comfortable with the expertise and training of the person who will be performing the procedure,” said Dr. Hanke. “However, it is imperative that a physician be on-site to evaluate patients prior to a procedure and to respond promptly to any questions or concerns during or after the procedure.”

  • Evaluate a physician’s credentials before considering a procedure.

Although it may be difficult for consumers to ask physicians about their credentials and professional background, Dr. Hanke believes this information is crucial for a safe result or outcome. According to Dr. Hanke, one of the most telling questions that consumers can ask physicians is whether they are board certified by one of the 24 boards of the American Board of Medical Specialties (ABMS), such as the American Board of Dermatology. He explained that board certification is important, as it could indicate a physician’s knowledge and experience with certain procedures.

In addition, consumers can research physicians on the Internet. State medical board Web sites typically offer information on physicians at no charge. “If a person isn’t comfortable broaching the subject of credentials with a physician, there are ways to research this information online,” said Dr. Hanke. “What’s important is that consumers do their homework before selecting a physician.”

Dr. Hanke also pointed out that physicians who are members of professional associations must meet certain qualifying standards as part of their membership. Professional organizations such as the American Academy of Dermatology and the American Society for Dermatologic Surgery offer members high-quality, accredited educational courses to learn about the most recent advances in the field and to refine their skills.

  • Discuss where the procedure will be performed and if office-based surgery is an option.

"A fully equipped physician's office that follows accepted standards for safety is an excellent option for patients to undergo a minimally invasive cosmetic procedure,” said Dr. Hanke. “Compared to hospitals and ambulatory surgery centers, office-based surgery provides many advantages – including decreased costs, greater privacy, efficiency and less risk of infection.”

The Academy also cautions consumers to avoid cosmetic procedures performed by non-physicians in spas, shopping malls and private parties or functions. While these venues may appear convenient or more cost-effective than a traditional medical setting, they are not necessarily equipped to handle complications or medical emergencies.

“The success of any cosmetic procedure depends on patients doing their homework up front and selecting a qualified physician to ensure a safe and successful outcome,” said Dr. Hanke. “A good doctor/patient relationship is extremely important, and it increases the likelihood that a patient will feel comfortable asking the physician critical questions and discussing their expectations and concerns.”

For more information on cosmetic procedures, go to the “AgingSkinNet” section of www.skincarephysicians.com, an Academy Web site developed by dermatologists that provides patients with up-to-date information on the treatment and management of disorders of the skin, hair and nails.

Headquartered in Schaumburg, Ill., the American Academy of Dermatology (Academy), founded in 1938, is the largest, most influential, and most representative of all dermatologic associations. With a membership of more than 16,000 physicians worldwide, the Academy is committed to: advancing the diagnosis and medical, surgical and cosmetic treatment of the skin, hair and nails; advocating high standards in clinical practice, education, and research in dermatology; and supporting and enhancing patient care for a lifetime of healthier skin, hair and nails. For more information, contact the Academy at 1-888-462-DERM (3376) or www.aad.org.

]]>tag:aad.org,2009-00-29:news/releases/Consumer_Alert_Minimally_Invasive_Cosmetic_Procedu2009-07-29T12:58:34-08:00Dermatologists Shed Light on Common Pigmentation Problems and Solutions in Skin of Color2009-07-29T12:00:00-08:00
At the American Academy of Dermatology’s Summer Academy Meeting 2009 in Boston, dermatologist Jonith Y. Breadon, MD, FAAD, co-chair of Dermasurgery at John H. Stroger, Jr. Hospital of Cook County in Chicago, discussed pigmentation problems that occur more frequently in darker-skinned patients and how early diagnosis is key to stopping the progression of these skin conditions.

“Even though people with skin of color have less moles and experience less premature aging from the sun than lighter-skinned individuals, in some ways their darker pigmentation makes their skin more vulnerable to other skin problems,” said Dr. Breadon. “While these skin discolorations can be stubborn, there are treatments that offer noticeable improvement.”

Hyperpigmentation
One of the most common pigmentation problems in darker-skinned individuals is hyperpigmentation (or the darkening of the skin). Usually the result of some type of inflammation or injury to the skin, such as a cut, burn or scrape, hyperpigmentation produces darkened areas of the skin that can last months or years. Even healed acne lesions can leave permanent dark spots in darker-skinned people that, in some cases, can be more distressing than the original acne.

Dr. Breadon noted that treatments for hyperpigmentation are based on whether or not the dark areas are confined to the surface of the skin or if they have penetrated to the deeper layers of the skin. For superficial dark spots, a prescription topical medication consisting of hydroquinone, retinoic acid and mild hydrocortisone can be effective in fading skin discoloration. Deeper dark areas require an in-office surgical procedure, such as dermabrasion, chemical peels, or microdermabrasion with an infusion of hydroquinone solution. In patients with lighter skin, intense pulsed light (IPL) or one of the pigmented lasers could be considered.

“Patients with any type of hyperpigmentation problem need to use a sunscreen with a high sun protection factor (SPF) regularly – the higher SPF the better,” said Dr. Breadon. “There is no cure for this condition, so even when patients experience clearing, it can come back. For most patients, I usually recommend a three-month topical regimen then long-term maintenance with a sunscreen.”

Melasma
Often referred to as the “mask of pregnancy,” melasma is a skin condition marked by brown patches on areas such as the face, neck and arms that most often affects dark-skinned people and women in particular. Many dermatologists have long believed that there may be a hormonal component to melasma, and a recently published study found that there were an increased number of estrogen receptors in areas where patients developed melasma.

For this reason, Dr. Breadon advises patients with melasma to consider stopping oral contraceptives and hormone replacement therapy due to the large amount of estrogens in these medications. Regular sunscreen use is vital to protect the skin from further hyperpigmentation.

With melasma, the skin can be affected in three different ways: on the epidermis (superficial layer), in the dermis (deep layer) or a mixture of both the epidermis and dermis. Dermatologists use a light device known as the Woods lamp, which shows skin diseases as specific colors, to determine how deep melasma has penetrated the skin.

For superficial melasma, the triple cream combination of hydroquinone, retinoic acid and mild hydrocortisone with regular sunscreen use can be effective, with clearance occurring in about three months for most patients. Dr. Breadon noted that cases where melasma has penetrated the dermis are very difficult to treat and the combination triple cream medication will not be effective in these patients.

However, some patients may experience improvement with microdermabrasion, dermabrasion, chemical peels or lasers. In cases where both the epidermis and the dermis are involved, the triple cream medication may offer some improvement for some patients.

“Melasma is hard to define, as it can occur in women during or after pregnancy or in women who have never been pregnant or used oral contraceptives,” said Dr. Breadon. “While lasers can be effective, there are risks of further hyperpigmentation and results vary greatly from person to person. Dermatologists can help patients decide the best course of treatment, depending on the severity of the condition.”

Lichen Planus
Lichen planus is a common inflammatory disease of the skin and the mouth that is characterized by a rash of round, or oval, violet-colored lesions. While lichen planus can affect people of all races and genders, it is more pronounced in people with darker skin since, as the lesions heal, the affected skin can develop very dark, leopard-looking spots.

When caught early, steroid injections are used to reduce the inflammation thereby minimizing hyperpigmentation. However, if the condition progresses before it can be treated and dark spots appear, Dr. Breadon explained that the triple cream topical medication, mild or systemic steroids, or lasers can be used with varying degrees of success to try to lighten the darkened areas of the skin.

“Detecting lichen planus early can make all the difference between spots that heal without hyperpigmentation and spots that are extremely pronounced and do not fade on their own,” said Dr. Breadon. “That’s why it is critical that people who experience an unexplained rash see their dermatologist immediately for proper diagnosis and treatment.

Ashy Dermatosis
Another skin condition that affects people of color, and especially African-Americans, is ashy dermatosis. While the cause of ashy dermatosis is unknown, it usually starts as a flat, dark grayish-brown rash that appears bi-laterally (or on both sides of body, such as both arms or both legs).

Ashy dermatosis closely resembles a condition known as fixed drug eruption, which causes the same type of pigmentation problem and is the result of an allergy to a food, medication or workplace trigger. For example, one of Dr. Breadon’s patients with this type of rash noticed a flare when she would consume a particular sugar substitute – which was eventually identified as the trigger.

“Based on my evaluation of numerous cases of ashy dermatosis and fixed drug eruption, my theory is that these two conditions are actually one in the same,” said Dr. Breadon. “That’s why I think it is so important to identify the trigger, as this can help alleviate the rash and prevent its spread. I encourage my patients to keep a food diary or a list of any medications or items with which they come into contact to see if we can identify the source of the problem.”

Dr. Breadon noted that ashy dermatosis and fixed drug eruption can be very difficult to treat. A compound lotion of salicylic acid, a mid-potency steroid and hydroquinone can offer gradual clearing. Regular use of sunscreen with a high SPF also is highly recommended to avoid further hyperpigmentation.

“It is important for people with darker skin to be aware of any changes in their skin and to see a dermatologist at the first sign of anything unusual,” said Dr. Breadon. “Dermatologists not only can diagnose and provide the best treatment options for a particular pigmentation problem, but also can rule out a serious condition, such as skin cancer.”

Headquartered in Schaumburg, Ill., the American Academy of Dermatology (Academy), founded in 1938, is the largest, most influential, and most representative of all dermatologic associations. With a membership of more than 16,000 physicians worldwide, the Academy is committed to: advancing the diagnosis and medical, surgical and cosmetic treatment of the skin, hair and nails; advocating high standards in clinical practice, education, and research in dermatology; and supporting and enhancing patient care for a lifetime of healthier skin, hair and nails. For more information, contact the Academy at 1-888-462-DERM (3376) or www.aad.org. ]]>tag:aad.org,2009-00-29:news/releases/Dermatologists_Shed_Light_on_Common_Pigmentation_P2009-07-29T12:58:57-08:00Frances J. Storrs, MD, FAAD, Delivers American Academy of Dermatology’s Everett C. Fox, MD, Memorial Lectureship2009-07-29T12:00:00-08:00
The Everett C. Fox, MD, Memorial Lectureship was created through a bequest from the estate of Everett C. Fox, MD, who served as vice president of the American Academy of Dermatology in 1946.

During Dr. Storrs’ lecture, “Forty Years of Fun with Contact Dermatitis,” she reflected on some of the fascinating learning experiences and enlightening encounters that she has had throughout her forty years of analyzing and treating patients with contact dermatitis. She emphasized the importance of performing more patch tests, which can help uncover problems that, when found, can dramatically change patients’ lives. Dr. Storrs noted that each of her patient experiences has taught her something she could use to solve new problems.

Dr. Storrs is director of the Contact and Occupational Skin Disease Clinic and in private practice at Oregon Health & Science University in Portland. After receiving her medical degree from Cornell Medical College in New York, she completed an internship at Good Samaritan Hospital in Portland, Ore., and a residency in dermatology at Oregon Health & Science University.

An active member in the dermatology community, Dr. Storrs is a past member of the Academy’s board of directors and has served on many committees and task forces. She is also a past president of the Oregon Dermatology Society and the American Contact Dermatitis Society, and has authored numerous articles, editorials and book chapters.

Headquartered in Schaumburg, Ill., the American Academy of Dermatology (Academy), founded in 1938, is the largest, most influential, and most representative of all dermatologic associations. With a membership of more than 16,000 physicians worldwide, the Academy is committed to: advancing the diagnosis and medical, surgical and cosmetic treatment of the skin, hair and nails; advocating high standards in clinical practice, education, and research in dermatology; and supporting and enhancing patient care for a lifetime of healthier skin, hair and nails. For more information, contact the Academy at
1-888-462-DERM (3376) or www.aad.org. ]]>tag:aad.org,2009-00-29:news/releases/Frances_J_Storrs_MD_FAAD_Delivers_American_Academy2009-07-29T12:59:14-08:00American Academy of Dermatology Issues Updated Position Statement on Vitamin D2009-07-14T12:00:00-08:00
The Academy continues to recommend that the public obtain vitamin D from nutritional sources and dietary supplements, and not from unprotected exposure to ultraviolet (UV) radiation from the sun or indoor tanning devices, as UV radiation is a known risk factor for the development of skin cancer.

The Academy’s position statement on vitamin D now also states that individuals who regularly and properly practice sun protection, such as the daily use of sunscreen on exposed skin or the wearing of sun protective clothing, may be at risk for vitamin D insufficiency. A higher dose of vitamin D may be necessary for these individuals and others with known risk factors for vitamin D insufficiency, such as those with dark skin, the elderly, photosensitive individuals, people with limited sun exposure, obese individuals or those with fat malabsorption. Therefore, the Academy encourages those with concerns about their levels of vitamin D to discuss options for obtaining sufficient dietary or supplementary sources of vitamin D with their physician.

“The vitamin D position statement supports the Academy’s long-held conviction on safe ways to get this important vitamin – through a healthy diet which incorporates foods naturally rich in vitamin D, vitamin D-fortified foods and beverages, and vitamin D supplements,” stated dermatologist David M. Pariser, MD, FAAD, president of the American Academy of Dermatology. “The updated recommendation for individuals who practice daily sun protection acknowledges that while protecting the skin from the damaging rays of the sun is important, so is maintaining adequate vitamin D levels. Concern about vitamin D should not lead people to forego sun protection, but rather prompt a conversation with their physician about how to ensure adequate and safe vitamin D intake while guarding against skin cancer .”

The Academy’s new position statement notes that the National Academy of Sciences Institute of Medicine guidelines for vitamin D are the standard reference for advising patients on proper minimum intake levels. The currently recommended adequate intake levels established by the Institute of Medicine may be revised upward due to evolving research on the increasing clinical benefit of vitamin D. The statement also notes that the U.S. Department of Agriculture (USDA) Dietary Guidelines discuss a daily total dose of 1,000 IU (International Units) of vitamin D for supplementation of those at-risk for vitamin D insufficiency.

The Academy’s new position statement also asserts that there is no scientifically proven, safe threshold of sun or indoor tanning device exposure that allows for maximum vitamin D synthesis in the skin without increasing the risk of skin cancer. Also, while numerous studies suggest an association between low levels of vitamin D and an increased risk of certain types of cancers and diseases, the Academy emphasizes that the causal relationship of vitamin D to these disease outcomes has yet to be demonstrated with clinical trials.

“It is well documented in the medical literature that unprotected exposure to UV radiation from natural sunlight or indoor tanning devices causes skin damage. There is no current research available that provides a safe limit for sun exposure to maximize vitamin D production that does not put the individuals health at risk for developing skin cancer,” stated Dr. Pariser. “In addition, contrary to some reported information about vitamin D and the prevention of certain cancers and diseases--other than for bone health, we simply need more clinical data to determine what role, if any, vitamin D plays in these conditions.”

The Academy continues to recommend that individuals protect themselves from UV exposure when outdoors, such as seeking shade whenever possible, wearing sunscreen and covering up with a wide-brimmed hat, long sleeves, pants and sunglasses. Also, the Academy urges the public to avoid tanning beds.

For more information about skin cancer, please visit the SkinCancerNet section on www.skincarephysicians.com, a Web site developed by dermatologists that provides the public with up-to-date information on the treatment and management of disorders of the skin, hair and nails.

Headquartered in Schaumburg, Ill., the American Academy of Dermatology (Academy), founded in 1938, is the largest, most influential, and most representative of all dermatologic associations. With a membership of more than 16,000 physicians worldwide, the Academy is committed to: advancing the diagnosis and medical, surgical and cosmetic treatment of the skin, hair and nails; advocating high standards in clinical practice, education, and research in dermatology; and supporting and enhancing patient care for a lifetime of healthier skin, hair and nails. For more information, contact the Academy at 1-888-462-DERM (3376) or www.aad.org. ]]>tag:aad.org,2009-00-14:news/releases/American_Academy_of_Dermatology_Issues_Updated_Pos2009-07-14T10:01:40-08:00Dates of 2009 ABD Examinations2009-07-09T12:00:00-08:00
Recertification Examination (administered online): May 1 to June 12, 2009. Deadline for receipt of applications: December 15, 2008. Note that this will be the last online open-book examination. Beginning in 2010, the recertification examination will be a proctored examination.

Certifying Examination (held at the testing centers of the American Board of Pathology in Tampa, Florida and the American Board of Radiology in Tucson, Arizona): August 3-7, 2009. Deadline for receipt of applications: March 1, 2009.

Subspecialty certification examination in Dermatopathology (administered at the testing center of the American Board of Pathology in Tampa, Florida): September 16, 2009. Deadline for receipt of applications: May 1, 2009. (Dermatologists must submit applications to the American Board of Dermatology office and pathologists to the American Board of Pathology office.)

The next subspecialty certification examination in Pediatric Dermatology will be administered in 2010; date and location to be determined.

For further information about these examinations, contact the ABD office (address and phone numbers below) or check the ABD website at www.abderm.org.

Antoinette F. Hood, M.D.
Executive Director
American Board of Dermatology
Henry Ford Health System
1 Ford Place
Detroit, MI 48202-3450
Telephone: 313-874-1088
FAX: 313-872-3221
E-mail address: abderm@hfhs.org ]]>tag:aad.org,2009-00-09:news/releases/Dates_of_2009_ABD_Examinations2009-01-02T01:27:16-08:00Winners of the Addressing Psoriasis™ Contest Selected to Walk the Runway in New York City Fashion Show Hosted by Tim Gunn2009-07-06T12:00:00-08:00Addressing Psoriasis™ contest, which recognizes people with moderate to severe plaque psoriasis who have tried not to allow the condition to inhibit their personal style. The winners will help raise public awareness of the condition by walking the runway in the Addressing Psoriasis™ Fashion Show hosted by television host and fashion consultant, Tim Gunn (“Project Runway,” and “Tim Gunn’s Guide to Style”), on Sept. 2, 2009.

The Addressing Psoriasis™ contest is the cornerstone of an awareness campaign designed to help people with plaque psoriasis get more information about managing their disease and feel more confident in their everyday style. Since March, hundreds of people with moderate to severe plaque psoriasis have submitted video testimonials or personal essays explaining their stories of overcoming the challenges of living with the condition and how it has impacted their personal style and the clothing they wear. As indicated in the Official Rules, judging was based on three levels of review and a panel of judges – including representatives from the American Academy of Dermatology (AAD), National Psoriasis Foundation (NPF), Psoriasis Cure Now (PCN), Amgen and Wyeth – selected the eight winners based on the inspirational nature of their stories.
The contest winners include:

  • Matthew Ehnle of Encampment, Wyo.
  • Isabel Esteviz of Lynwood, Ill.
  • Trisha Lagaso Goldberg of Aiea, Hawaii 
  • Laura Hurd of Denver, Colo. 
  • Cynthia Lawrence of Hanover, Pa. 
  • Cynthia McGowen of League City, Texas 
  • Saskia Shuman of Harrisburg, Pa. 
  • Stephanie Waits of San Francisco, Calif.

As part of the contest, the general public – including those without psoriasis – are now encouraged to vote for the most inspirational story among the eight winners. The contest winner whose story is voted most inspirational will be announced by Gunn at the Addressing Psoriasis™ Fashion Show and subsequently recognized on the Addressing Psoriasis™ Web site. To learn more about the winners, vote on the most inspirational story, view the Official Rules, find useful resources about psoriasis and obtain style tips from Gunn, visit www.addresspsoriasis.com.

“Confidence and style go hand-in-hand, and these contest winners have clearly demonstrated that personal style can thrive even with a chronic disease like psoriasis,” said Gunn. “I find all of these individuals inspiring, and I am curious to find out which story the voting public considers most inspirational – I think it will be very difficult for people to pick just one.”

Psoriasis, which affects nearly 7 million Americans, is a chronic disease of the immune system that causes the skin cells to grow at an accelerated rate. Although there are several types of psoriasis, approximately 80 percent of patients suffer from plaque psoriasis, which causes painful and itchy red, scaly patches. People with psoriasis often experience feelings of self-consciousness and choose their clothing because of the appearance of their skin.

The fashion show will feature custom-made ensembles for each of the eight winners designed by emerging talent from the acclaimed Fashion Institute of Technology (FIT) in New York.

“FIT is proud to be participating in the Addressing Psoriasis™ Fashion Show, which we feel will provide our students an invaluable design experience that is tied to an important cause,” said Eileen Karp, assistant professor and contest coordinator for Fashion Design at FIT. “Our students are designing unique outfits for each of the winners that are comfortable and representative of their individual fashion choices. Psoriasis is a disease that can inhibit self-confidence in personal style, and FIT is an institution that celebrates self-expression through fashion – in our eyes, there could be no better match!”

About Addressing Psoriasis™
The Addressing Psoriasis™ campaign was developed to inspire people with plaque psoriasis to be confident and not allow the condition to inhibit their everyday style. Addressing Psoriasis™ is sponsored by Amgen and Wyeth with participation from the American Academy of Dermatology, the National Psoriasis Foundation and Psoriasis Cure Now. To learn more about Addressing Psoriasis™, visit www.addresspsoriasis.com.

About Amgen and Wyeth
Amgen discovers, develops, manufactures and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, and other serious illnesses. With a deep and broad
pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives. To learn more about our pioneering science and our vital medicines, visit www.amgen.com.

Wyeth Pharmaceuticals, a division of Wyeth, has leading products in the areas of women’s health care, infectious disease, gastrointestinal health, central nervous system, inflammation, transplantation, hemophilia, oncology, vaccines and nutritional products. Wyeth is one of the world’s largest research-driven pharmaceutical and health care products companies. It is a leader in the discovery, development, manufacturing and marketing of pharmaceuticals, vaccines, biotechnology products and non-prescription medicines that improve the quality of life for people worldwide. The Company’s major divisions include Wyeth Pharmaceuticals, Wyeth Consumer Healthcare and Fort Dodge Animal Health. To learn more, visit www.wyeth.com.

About American Academy of Dermatology
Headquartered in Schaumburg, Ill., the American Academy of Dermatology (Academy), founded in 1938, is the largest, most influential, and most representative of all dermatologic associations. With a membership of more than 15,000 physicians worldwide, the Academy is committed to: advancing the diagnosis and medical, surgical and cosmetic treatment of the skin, hair and nails; advocating high standards in clinical practice, education, and research in dermatology; and supporting and enhancing patient care for a lifetime of healthier skin, hair and nails. For more information, contact the Academy at 1-888-462-DERM (3376) or http://www.aad.org.

About National Psoriasis Foundation
The National Psoriasis Foundation is the world's largest nonprofit patient advocacy organization and the voice for millions of Americans who are affected by psoriasis and psoriatic arthritis. Our mission is to find a cure for psoriasis and psoriatic arthritis and to eliminate their devastating effects through research, advocacy and education. For more information, call the Psoriasis Foundation at 800.723.9166, or visit www.psoriasis.org.

About Psoriasis Cure Now
Psoriasis Cure Now is a nonprofit organization fueled by a nationwide network of volunteers. Our focus is on accelerating the search for a cure by mobilizing people in support of increased research funding for psoriasis and psoriatic arthritis. We also work to educate psoriasis patients about their treatment options and the public about the seriousness of psoriasis. http://www.psoriasis-cure-now.org.

About the Fashion Institute of Technology
The Fashion Institute of Technology is a college of art and design, business and technology of the State University of New York with more than 40 majors, including Fashion Design. The Fashion Design degree program at FIT prepares students to excel and flourish in the fashion industry. The program’s philosophy focuses on individual student development with an emphasis on professionalism. The learning environment broadens students’ aesthetics, critical thinking and problem-solving skills. FIT’s Fashion Design program leads to the Associate of Applied Sciences and Bachelor of Fine Arts degrees.

]]>tag:aad.org,2009-00-06:news/releases/Winners_of_the_Addressing_Psoriasis_Contest_Select2009-07-07T09:55:01-08:00American Academy of Dermatology Association Commends Texas for Enacting the Most Restrictive Indoor Tanning Law in the Country2009-06-22T12:00:00-08:00
“The American Academy of Dermatology Association applauds the state of Texas for being the first in the nation to prohibit the use of indoor tanning devices for all children and adolescents under the age of 16.5 – the most restrictive law in the country,” said dermatologist Evan Farmer, MD, FAAD, vice president of the American Academy of Dermatology Association. “We commend Governor Perry, Representative Solomons and the other members of the Texas legislature for their efforts to help reduce the incidence of skin cancer by protecting youth from the dangers of indoor tanning.”

The United States Department of Health and Human Services has stated that ultraviolet (UV) radiation from the sun and artificial sources, such as tanning beds and sun lamps, is a known carcinogen. Yet, nearly 30 million people tan indoors in the United States annually. Of these, 2.3 million are teens.

Indoor tanning before the age of 35 has been associated with a significant increase in the risk of melanoma, the deadliest form of skin cancer. More than 1 million new cases of skin cancer will be diagnosed in the United States this year. Limiting exposure to UV radiation from the sun and artificial sources, such as tanning beds and sun lamps, is the best way to reduce the risk of skin cancer.

“Helping children develop healthy habits and avoid excessive exposure to ultraviolet radiation will decrease their risk of skin cancer and other potential hazards such as eye damage, aging skin and immune suppression,” said Dr. Farmer. “Texas’ leadership on this issue will serve as a model for other states to improve their laws and regulations on this critical public health issue.”

The American Academy of Dermatology (Academy), founded in 1938, is the largest, most influential, and most representative of all dermatologic associations. A sister organization to the Academy, the American Academy of Dermatology Association is the resource for government affairs, health policy and practice information for dermatologists, and plays a major role in formulating socioeconomic policies that can enhance the quality of dermatologic care. With a membership of more than 16,000 physicians worldwide, the Academy is committed to: advancing the diagnosis and medical, surgical, and cosmetic treatment of the skin, hair and nails; advocating high standards in clinical practice, education, and research in dermatology; and supporting and enhancing patient care for a lifetime of healthier skin. For more information, contact the Academy at 1-888-462-DERM (3376) or www.aad.org. ]]>tag:aad.org,2009-00-22:news/releases/American_Academy_of_Dermatology_Association_Commen12009-08-04T02:21:13-08:00American Academy of Dermatology Appoints New Officer and Board Member2009-06-16T12:00:00-08:00
Suzanne M. Olbricht, MD, FAAD, a Newton, Mass., dermatologist has been appointed by the Academy’s board of directors as its assistant secretary-treasurer. She will succeed Robert D. Greenberg, MD, when he becomes secretary-treasurer at the conclusion of the Academy’s 2010 Annual Meeting.

Earlier this year, Ronald L. Moy, MD, FAAD, was elected 2010 president-elect of the Academy, which created a one-year vacancy on the board of directors. The board appointed Darryl M. Bronson, MD, MPH, FAAD, a Highland Park, Ill., dermatologist in private practice, to complete Dr. Moy’s term at the close of the 2010 Annual Meeting.

Drs. Olbricht and Bronson will lead the world’s largest dermatologic society, representing more than 16,000 physicians specializing in the diagnosis and medical, surgical and cosmetic treatment of skin, hair and nail conditions. They also will hold the same positions for the American Academy of Dermatology Association.

Dr. Olbricht is the chair of the department of dermatology at the Lahey Clinic in Burlington, Mass., and an associate professor of dermatology at Harvard Medical School in Boston. As a member of the Academy’s scientific assembly committee, she is the chair of the Summer Academy Meeting 2009 and will chair the 70th Annual Meeting in 2012. She also currently serves as treasurer of the Women’s Dermatologic Society and is a member of the American College of Mohs Surgery’s board of directors. In addition, she has served as president, vice president, and secretary of the New England Dermatology Society.

Dr. Bronson is immediate past chairman and residency program director of the division of dermatology at John H. Stroger, Jr. Hospital of Cook County in Chicago, a former professor of dermatology and pathology at Rush Medical College in Chicago and a former clinical professor of dermatology at the University of Illinois. He has served on the executive committee of the Academy’s advisory board and has chaired two Academy task forces. In addition, Dr. Bronson is immediate past president and secretary-treasurer of the Noah Worcester Dermatological Society and a past president of the Illinois Dermatological Society and the Chicago Dermatological Society.

The American Academy of Dermatology (Academy), founded in 1938, is the largest, most influential, and most representative of all dermatologic associations. A sister organization to the Academy, the American Academy of Dermatology Association is the resource for government affairs, health policy and practice information for dermatologists, and plays a major role in formulating socioeconomic policies that can enhance the quality of dermatologic care. With a membership of more than 16,000 physicians worldwide, the Academy is committed to: advancing the diagnosis and medical, surgical, and cosmetic treatment of the skin, hair and nails; advocating high standards in clinical practice, education, and research in dermatology; and supporting and enhancing patient care for a lifetime of healthier skin. For more information, contact the Academy at 1-888-462-DERM (3376) or www.aad.org. ]]>tag:aad.org,2009-00-16:news/releases/American_Academy_of_Dermatology_Appoints_New_Offic2009-06-16T01:03:55-08:00American Academy of Dermatology Issues New Guidelines for the Management of Psoriasis with Systemic Medications2009-06-04T12:00:00-08:00
Published online in the Journal of the American Academy of Dermatology, this is the Academy’s fourth of six sections of the guidelines of care for psoriasis, with three previously published sections focusing on general recommendations for the treatment of psoriasis and psoriatic arthritis, as well as the use of biologics and topical therapies.

“While in recent years biologics have changed the treatment of psoriasis, traditional systemic therapies – which are easily administered orally and less expensive than biologics – continue to play an important role in treating psoriasis,” said dermatologist David M. Pariser, MD, FAAD, president of the Academy. “The Academy’s new evidence-based guidelines are intended as a guide for physicians so the best treatment can be determined for each individual patient. The guideline also discussed any potential side effects or risk factors that need to be evaluated prior to treatment.”

Psoriasis is a chronic skin condition, which usually begins before age 35 and is characterized by thick, red, scaly patches that itch and bleed. Although it is a genetic disease, it is not completely understood how it is inherited. However, there are at least eight chromosomes to date that researchers have identified as being linked to the genetic transmission of the disease.

Although a prerequisite to starting a systemic therapy traditionally has been whether a patient is affected by psoriasis over a minimum body surface area of about 10 percent, a subset of patients with limited psoriasis have debilitating symptoms on their palms, soles or scalp that can significantly impact their quality of life – making systemic treatments an appropriate option for them.

Methotrexate
As the most commonly prescribed traditional systemic therapy for psoriasis, methotrexate can be very effective with even the most severe cases of psoriasis. Methotrexate works by competitively inhibiting the enzyme dihydrofolate reductase, which decreases the production of folic acid thus blocking DNA synthesis and cell division.

Efficacy & Dosage
In the only placebo-controlled trial of methotrexate for psoriasis, 36 percent of patients treated with a low weekly dosage of 7.5 mg of methotrexate – which was increased as needed up to 25 mg per week – achieved a 75 percent or greater improvement in their Psoriasis Area and Severity Index (PASI) score after 16 weeks. In general, methotrexate is administered as a single weekly oral dose that can be increased gradually until an optimal response is achieved. Although there are no established maximum or minimum dosages of methotrexate, weekly dosages usually range from 7.5 mg to 25 mg.

“Some patients can be gradually tapered off treatment and restarted when the psoriasis recurs, and it is important for physicians to minimize the total cumulative dose of methotrexate while maintaining adequate control of psoriasis and the patient’s tolerance of the medication,” said Dr. Pariser.

Toxicities & Contraindications
Because of the known organ toxicities of traditional systemic medications, proper patient selection and appropriate monitoring are crucial to minimize the toxicity of any therapy. For example, the most common and generally minor side effects of methotrexate that most often occur at the time it is administered include nausea, fatigue, inflammation of the mucous membranes of the mouth and anorexia. The most serious toxicities associated with methotrexate are white blood cell and platelet deficiency, liver damage and lung scarring.

Since methotrexate can cause birth defects or terminate a pregnancy, it is not prescribed to women attempting to conceive. In addition, methotrexate should not be prescribed to nursing mothers, those with chronic liver disease, alcoholics, or patients with immunodeficiency syndromes, among others.

Cyclosporine
Cyclosporine is one of the most effective treatments for psoriasis and induces immunosuppresion by inhibiting the first phase of T-cell activation.

When the medication is used long-term (i.e., three to five years), a significant number of patients will develop some degree of glomerulosclerosis, scarring of the kidney’s blood vessels. For this reason, Dr. Pariser noted that published guidelines in the United States limit the use of cyclosporine to one year.

Efficacy & Dosage
Numerous clinical trials have demonstrated the efficacy of cyclosporine used as a short-term treatment for psoriasis, with minimal toxicities in healthy patients. Specifically, studies show at 3 mg/kg and 5 mg/kg per day, 36 percent and 65 percent of patients, respectively, achieved a clear or almost clear result after eight weeks. In addition, after eight to 16 weeks, 50 to 70 percent of patients achieved a 75 percent or greater improvement in their PASI score. Cyclosporine is generally prescribed to adult, non-immunocompromised patients with severe psoriasis who have not responded to at least one systemic therapy or in patients who cannot tolerate other systemic medications.

Generally, dosing of cyclosporine is given as 2.5 mg/kg to 5.0 mg/kg a day in two divided doses, and physicians should make decreased dose adjustments by 0.5 mg/kg to 1.0 mg/kg when psoriasis is cleared or when high blood pressure or decreased kidney function test results are observed.

Toxicities & Contraindications
The most serious side effects associated with cyclosporine are kidney damage and high blood pressure, which is why it requires careful patient selection and subsequent monitoring to be used safely. A number of drug interactions can occur with this medication, and the FDA advises that it should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.

“Studies also show that patients with psoriasis taking cyclosporine may be at increased risk of developing squamous cell carcinoma, particularly those with a history of more than 200 PUVA treatments,” said Dr. Pariser. “Due to these known toxicities and contraindications, a careful assessment of a psoriasis patient’s disease severity is critical when assessing the risk-benefit ratio of treatment with cyclosporine.”

Acitretin
Acitretin is an oral retinoid, which is derived from vitamin A. Although the exact way retinoids work in the treatment of psoriasis is not completely understood, they are known to inhibit excessive cell growth and stimulate differentiation of the epidermis (outermost layer of the skin). Etretinate was the first retinoid introduced for the treatment of severe psoriasis and was replaced by acitretin, the active metabolite of etretinate, in 1988.

Efficacy & Dosage
Clinical studies suggest that when used alone, acitretin is the least effective of the traditional systemic therapies and is therefore often used in conjunction with ultraviolet (UV) light. The effectiveness of acitretin is dose dependent, with dosing ranging from 10 mg to 50 mg per day administered as a single dose.

“Typically, it takes three to six months for acitretin to achieve the desired response in most psoriasis patients,” explained Dr. Pariser. “Appropriate dosing must take into account the balance among safety, tolerability and efficacy, as many patients may not be able to tolerate the higher dosages of acitretin needed for optimal efficacy.”

Toxicities & Contraindications
Several potential adverse effects are associated with acitretin, such as alopecia, nausea and abdominal pain, and joint and muscle pain, to name a few. However, Dr. Pariser explained that these can generally be minimized by appropriate patient selection, careful dosing and monitoring. As is the case with methotrexate, acitretin’s most serious side effect is its potential to cause birth defects. Therefore, its use is limited to male and female patients of non-childbearing potential. In addition, other increased risks include severely impaired liver or kidney function and chronic, abnormally elevated blood lipid values. For this reason, patients should be monitored with lipid profiles and liver enzymes once every two weeks after starting acitretin.

“These guidelines emphasize that the decision to prescribe methotrexate, cyclosporine, acitretin or any other traditional therapy must be individualized,” said Dr. Pariser. “Under the right circumstances, systemic therapies can significantly improve even the more severe cases of psoriasis. But every patient needs to be carefully evaluated in terms of disease severity, quality of life, and general medical and psychological history. Dermatologists and patients must work together to continually review the response to treatment and potential risks.”

To learn more about psoriasis, visit the PsoriasisNet section of www.skincarephysicians.com, a Web site developed by dermatologists that provides patients with up-to-date information on the treatment and management of disorders of the skin, hair and nails.

Headquartered in Schaumburg, Ill., the American Academy of Dermatology (Academy), founded in 1938, is the largest, most influential, and most representative of all dermatologic associations. With a membership of more than 16,000 physicians worldwide, the Academy is committed to: advancing the diagnosis and medical, surgical and cosmetic treatment of the skin, hair and nails; advocating high standards in clinical practice, education, and research in dermatology; and supporting and enhancing patient care for a lifetime of healthier skin, hair and nails. For more information, contact the Academy at 1-888-462-DERM (3376) or www.aad.org. ]]>tag:aad.org,2009-00-04:news/releases/American_Academy_of_Dermatology_Issues_New_Guideli22009-07-06T01:28:53-08:00American Academy of Dermatology Recognizes Merz Pharmaceuticals2009-05-28T12:00:00-08:001

According to the AAD, sun exposure is the most preventable risk factor for all skin cancers, including melanoma, and is primarily responsible for premature aging.

“Public health education is the first line of defense against skin cancer,” said dermatologist David M. Pariser, M.D., president of the AAD. “The AAD SEAL OF RECOGNITION®, awarded only to those products that meet stringent, evidence-based scientific criteria for sun protection, helps raise public awareness of the dangers of unprotected sun exposure. Scars are particularly sensitive to the sun’s harmful ultraviolet A (UVA) and ultraviolet B (UVB) rays which can worsen the appearance of the scar. To help minimize the appearance of scars, it is imperative to protect the skin and apply sunscreen. The AAD recognizes that proper and regular use of broad-spectrum (UVA/UVB) protection sunscreens with Sun Protection Factor (SPF) 15 or higher, along with wearing sun-protective clothing and seeking shade, will help protect against sunburn and may reduce long-term damage to the skin caused by sun exposure.”

“Mederma® Cream plus SPF 30 is the only scar product with SPF 30 that can help reduce the appearance of scars and protect them from sun exposure,” said Mikael Svensson, Merz’ Vice President of Medical and Aesthetic Dermatology. “Mederma® Cream plus SPF 30 is effective on scars resulting from surgery, injury, burns, acne and stretch marks. As the #1 doctor-recommended brand for scars for 10 years, Mederma® is a product that delivers on its promises. It’s clinically proven to soften, smooth, and reduce the appearance of scars.”

Tips for scar management:
  • Because scars are sensitive to sun, apply Mederma® Cream plus SPF 30 thirty minutes prior to heading outdoors, so the skin has a chance to absorb the protective ingredients. If outside, reapply every two hours, or after every significant sporting activity or water submersion.2
  • Pressure bandages and massages can flatten some scars if used on a regular basis for several months.3
  • If cosmetics are applied correctly, they can be very effective at covering up scars. The correct make-up will improve the appearance while nature completes the healing process.4

About Mederma®
The Mederma® family of products, including Mederma® Gel, Mederma® for Kids, and Mederma® Cream plus SPF 30, has a long tradition of efficacy. Mederma® Cream plus SPF 30 is formulated to help reduce the appearance of scars and protect them from sun exposure. Mederma® Cream works for old and new scars resulting from surgery, injury, burns, acne and stretch marks. It's from the #1 doctor- and pharmacist-recommended brand for scars. To learn more, visit www.mederma.com.

About the American Academy of Dermatology
Headquartered in Schaumburg, Ill., the American Academy of Dermatology (Academy), founded in 1938, is the largest, most influential, and most representative of all dermatologic associations. With a membership of more than 16,000 physicians worldwide, the Academy is committed to: advancing the diagnosis and medical, surgical and cosmetic treatment of the skin, hair and nails; advocating high standards in clinical practice, education, and research in dermatology; and supporting and enhancing patient care for a lifetime of healthier skin, hair and nails. The Academy does not endorse or recommend any products or services. The AAD SEAL OF RECOGNITION® recognizes over-the-counter products for their sun-protection benefit based on review of independent testing results by an independent scientist and a panel of dermatologists to verify that the products meet stringent, evidence-based sun-protection criteria. For more information, contact the Academy at 1-888-462-DERM (3376) or www.aad.org.  

About Merz
Merz Pharmaceuticals, makers of Mederma® products, is a specialty pharmaceutical company dedicated to addressing unmet medical need with innovative health care solutions that improve self-esteem and quality of life. Merz distributes prescription Naftin® (naftifine HCl 1%) Cream and Gel and several non-prescription products, including Mederma®, the #1 doctor- and pharmacist-recommended brand for scars; Mederma® Cream plus SPF 30, formulated with SPF to help protect scars from sun exposure; Mederma® for Kids™, the #1 pediatrician-recommended product for children’s scars; Aqua Glycolic®, a dermatologist-recommended alpha hydroxy acid–based (AHA) skin care system; and Appearex®, the #1 dermatologist-recommended product for strengthening nails. Merz is known worldwide for its development of original compounds and formulations sold to medical professionals and consumers in over 90 countries. To learn more, visit www.merzusa.com.

1http://www.aad.org/Public/sun/seal/products.html
2http://www.fda.gov/cdrh/tanning/sunprotection.html
3http://www.aad.org/public/publications/pamphlets/cosmetic_scar.html
4http://www.aad.org/public/publications/pamphlets/cosmetic_scar.html ]]>tag:aad.org,2009-00-28:news/releases/American_Academy_of_Dermatology_Recognizes_Merz_Ph2009-08-04T02:22:23-08:00Study Finds That Patients With Excessive Sweating Condition Are More Likely To Develop Skin Infections2009-05-07T12:00:00-08:00
In the study entitled, “Primary hyperhidrosis increases the risk of cutaneous infection: A case-control study of 387 patients,” published online in the Journal of the American Academy of Dermatology, dermatologist Hobart W. Walling, MD, PhD, FAAD, who maintains a private practice in Coralville, IA, found that primary hyperhidrosis patients are more prone to skin infections than those without the condition.

Hyperhidrosis is categorized as either primary (not caused by a separate medical condition or medication) or secondary (caused by an underlying medical condition or medication). Primary hyperhidrosis affects nearly 3 percent of the U.S. population. Symptoms of primary hyperhidrosis include excessive sweating that lasts at least six months with at least two of the following additional characteristics: affects both sides of the body equally, occurs at least once weekly, begins at age 25 or younger, ceases during sleep, and has other family members with the condition.

Dr. Walling and a team of researchers collected medical records for 387 patients who had visited the University of Iowa Department of Dermatology and were diagnosed with primary hyperhidrosis. They also collected records for 410 age- and gender-matched patients who visited the same dermatology department during the same time period and were diagnosed with an unrelated condition.

“Many studies have focused on the social and psychological effects associated with hyperhidrosis, but few studies have focused on the medical consequences of the condition,” said Dr. Walling. “Our study set out to examine the physical signs and symptoms of primary hyperhidrosis and to determine the condition’s relationship to skin infections in the affected areas.”

Of the patients with primary hyperhidrosis, almost three-fifths (58.9%) were female and more than two-fifths (41.1%) were male. More than half of the patients (53.4%) experienced hyperhidrosis in one area of the body, while the remaining patients (46.6%) had multiple affected sites. The most frequently affected sites of hyperhidrosis reported by the patients were the soles (50.1%), followed by the palms (45.2%) and the underarms (43.4%). Other areas affected included the face, scalp, groin and torso, and some reported hyperhidrosis throughout the body.

In addition, a number of the primary hyperhidrosis patients (38.6%) gave information regarding factors that aggravated their condition. Patients noted stress, emotion, anxiety or social situations as the most common (56.7%). Some found that heat or humidity worsened their condition (22%), while others denied any aggravating factors (15.3%).

Dr. Walling and his research team examined the medical records of the primary hyperhidrosis patients in search of coexisting skin infections that affected the areas involved by hyperhidrosis. They then compared these results to the patients without hyperhidrosis who had been diagnosed with a skin infection that affected any area of the body.

The overall risk of developing a skin infection caused by bacteria, fungi or viruses was significantly higher for the patients with primary hyperhidrosis than those without (30% of patients with hyperhidrosis developed a skin infection versus 12.0% of those without). In particular, patients with primary hyperhidrosis had a significantly higher risk of developing a fungal infection in the areas affected by hyperhidrosis (12.1%) than the control group (2.7%). Similarly, the risk of bacterial infection was heightened in primary hyperhidrosis patients (5.4%) versus those in the control group (2.2%) as was the overall risk of viral infection (12.4% of patients versus 7.1% of controls). Also of note, an increased association with atopic or eczematous dermatitis was observed in patients with primary hyperhidrosis (9.3%) versus those without (3.4%).

“The patients in the study waited, on average, nearly nine years after experiencing symptoms of hyperhidrosis before they visited a dermatologist,” said Dr. Walling. “It is important that patients know that seeking treatment for hyperhidrosis not only will positively impact their quality of life, but it may help prevent skin infections from occurring and deter other associated complications.”

Dr. Walling recommends that if you experience excessive sweating over a prolonged period of time or perspiration that is not triggered by obvious factors, you should consult a dermatologist.

Headquartered in Schaumburg, Ill., the American Academy of Dermatology (Academy), founded in 1938, is the largest, most influential, and most representative of all dermatologic associations. With a membership of more than 15,000 physicians worldwide, the Academy is committed to: advancing the diagnosis and medical, surgical and cosmetic treatment of the skin, hair and nails; advocating high standards in clinical practice, education, and research in dermatology; and supporting and enhancing patient care for a lifetime of healthier skin, hair and nails. For more information, contact the Academy at 1-888-462-DERM (3376) or www.aad.org. ]]>tag:aad.org,2009-00-07:news/releases/Study_Finds_That_Patients_With_Excessive_Sweating_2009-07-02T01:59:06-08:00American Academy of Dermatology Recognizes Coolibar for Sun-Protective Clothing2009-05-04T12:00:00-08:00
The AAD SEAL OF RECOGNITION® recognizes products for their sun-protection benefit based on review of independent testing results which demonstrate that the products meet stringent, evidence-based sun-protection criteria and verified by a panel of dermatologists and an independent scientist. All Coolibar sun-protective clothing has a 50+ Ultraviolet Protection Factor (UPF) for the life of the garment. The company’s proprietary SUNTECT® fabrics are extremely light-weight, breathable, durable, easy care, and pass the most rigorous testing protocol for UV clothing fabrics in the world.

Skin Cancer Prevention with Sun Protection
According to the AAD, sun exposure is the most preventable risk factor for all skin cancers, including melanoma, and is primarily responsible for premature aging. “Public health education is the first line of defense against skin cancer,” said dermatologist David M. Pariser, M.D., president of the AAD. “The AAD SEAL OF RECOGNITION®, awarded only to those products that meet stringent evidence-based scientific criteria for sun protection, helps raise public awareness of the dangers of unprotected sun exposure. The AAD shares Coolibar’s passion for sun protection and its recommendation that everyone cover up with long sleeves, pants and wide brim hats. The AAD recognizes that proper and regular use of sunscreens with Sun Protection Factor (SPF) 15 or higher and broad-spectrum (UVA/UVB) protection, along with wearing sun-protective clothing and seeking shade, will help protect against sunburn and may reduce long-term damage to the skin caused by sun exposure.”

“The AAD SEAL OF RECOGNITION® alerts consumers to the need to choose quality products that will protect them from harmful ultraviolet radiation,” said John Barrow, founder and president of Coolibar. “The AAD recommends sun-protective clothing as an important part of a comprehensive sun-protection program. We are delighted by the AAD’s recognition of our clothing, which speaks to our expertise and product leadership within the sun-protective clothing market.”

Barrow is the co-author of Sun Protection For Life: Your Guide To A Lifetime of Healthy & Beautiful Skin (New Harbinger Publications, 2005). Coolibar also has sponsored two books for children (Lake Vacation) and teens (Pretty Prom Your Skin Is Pretty Too) providing advice about skin cancer prevention and detection. All three books won Gold Triangle Awards from the AAD for excellence in education of a dermatologic issue.

About the American Academy of Dermatology
Headquartered in Schaumburg, Ill., the American Academy of Dermatology (Academy), founded in 1938, is the largest, most influential, and most representative of all dermatologic associations. With a membership of more than 15,000 physicians worldwide, the Academy is committed to: advancing the diagnosis and medical, surgical and cosmetic treatment of the skin, hair and nails; advocating high standards in clinical practice, education, and research in dermatology; and supporting and enhancing patient care for a lifetime of healthier skin, hair and nails. For more information, contact the Academy at 1-888-462-DERM (3376) or www.aad.org.

About Coolibar
Coolibar was founded in 2001 to bring Australia's world-leading approaches to sun protection to the American market. The company has extensively redesigned Australian sun protective clothing styles to meet the tastes and needs of fashion- and health-conscious Americans. For information about Coolibar, go to www.coolibar.com or call 1-800-926-6509. ]]>tag:aad.org,2009-00-04:news/releases/American_Academy_of_Dermatology_Recognizes_Cooliba2009-08-04T02:23:13-08:00Dermatologists Encourage People To Screen The One You Love For Skin Cancer2009-05-04T12:00:00-08:00
Based on current estimates, more than 1 million cases of skin cancer will be diagnosed in the United States in 2009. When detected early, most skin cancers can be successfully treated. Performing regular skin self-examinations is an easy way to detect suspicious moles that could be cancerous, and research shows that involving a partner in the self-examination process can improve the early detection of skin cancer.

“People who check their skin regularly for any changes in existing moles or new moles are taking an important first step in detecting the early warning signs of skin cancer,” said dermatologist David M. Pariser, MD, FAAD, president of the Academy. “Asking a partner to help monitor your skin for any changes or to assist in examining hard-to-reach areas can be very beneficial in spotting skin cancer.”

To enhance a patient’s ability to detect skin cancer, the Academy has adopted the revised ABCDs of Melanoma Detection, which include an “E” for Evolving. A mole or skin lesion that is “Evolving” or changing in size, shape or color should be brought to the attention of a dermatologist. This is in addition to other characteristics of moles for which individuals should check their skin – Asymmetry (one half unlike the other half), Border (irregular, scalloped or poorly defined), Color (varies from one area to another; shades of tan and brown, black; sometimes white, red or blue), and Diameter (the size of a pencil eraser or larger). A mole with any of these characteristics, or one that is an “ugly duckling”, meaning it looks different from the rest, should be brought to a dermatologist’s attention.

A new study published in Cancer (December 15, 2008) examining changes in melanomas diagnosed over 35 years found that melanomas were frequently described by patients as evolving lesions. In this collaborative study conducted at the NYU Langone Medical Center, dermatologist David Polsky, MD, PhD, FAAD, associate professor of dermatology and pathology and director of the Pigmented Lesion Section of the Ronald O. Perleman Department of Dermatology, and colleagues studied 1,684 prospectively enrolled patients diagnosed with 1,734 melanomas. They observed important differences in the clinical behavior of nodular melanomas (very rapidly growing melanomas) compared to superficial spreading melanomas (the most common type of melanoma).

Among the key findings, Dr. Polsky reported that more than 90 percent of patients with nodular melanoma reported a history of change in the lesion and these patients were more likely to be diagnosed with thicker, more dangerous tumors. By comparison, 80 percent of patients with superficial spreading melanoma indicated a slower pace of change in the lesion, and over time these lesions were diagnosed earlier in their evolution, as thinner, less problematic, tumors.

“Nodular melanomas typically do not have the classic ABCD features that one might expect to find when doing a skin self-exam, as they can be one color and have smooth borders,” said Dr. Polsky. “But what’s important to note is that nodular melanomas do change over a few months time, especially in color or height, such as a bump on the skin. So, I think by modifying our detection criteria to include ‘evolving,’ the ABCDEs of Melanoma Detection will better encompass the characteristics of aggressive nodular melanomas and help patients better assess a dangerous mole.”

In addition, the Academy offers a Body Mole Map, a tool individuals can use to track their moles. The map provides information on how to perform a skin exam, images of the ABCDEs of melanoma and space for people to track their moles to determine any changes over time. Popular holidays, such as Mother’s Day (May 10), Father’s Day (June 21) and Grandparents Day (September 13) are reminders for people to check their loved ones’ skin for suspicious moles using the Academy’s Body Mole Map. The mole map is available at www.melanomamonday.org.
To minimize your risk of skin cancer, the Academy recommends that everyone Be Sun SmartSM :
  • Generously apply a broad-spectrum water-resistant sunscreen with a Sun Protection Factor (SPF) of at least 15 to all exposed skin. “Broad-spectrum” provides protection from both ultraviolet A (UVA) and ultraviolet B (UVB) rays. Re-apply every two hours, even on cloudy days, and after swimming or sweating. Look for the AAD SEAL OF RECOGNITION® on products that meet these criteria.
  • Wear protective clothing, such as a long-sleeved shirt, pants, a wide-brimmed hat and sunglasses, where possible.
  • Seek shade when appropriate, remembering that the sun's rays are strongest between 10 a.m. and 4 p.m. If your shadow is shorter than you are, seek shade.
  • Protect children from sun exposure by playing in the shade, using protective clothing, and applying sunscreen.
  • Use extra caution near water, snow and sand as they reflect the damaging rays of the sun which can increase your chance of sunburn.
  • Get vitamin D safely through a healthy diet that may include vitamin supplements. Don't seek the sun.
  • Avoid tanning beds. Ultraviolet light from the sun and tanning beds can cause skin cancer and wrinkling. If you want to look like you've been in the sun, consider using a sunless self-tanning product, but continue to use sunscreen with it.
  • Check your birthday suit on your birthday. If you notice anything changing, growing, or bleeding on your skin, see a dermatologist. Skin cancer is very treatable when caught early.

Monday, May 4, is Melanoma Monday® and the official launch of Melanoma/Skin Cancer Detection and Prevention Month®. Through the Academy’s National Melanoma/Skin Cancer Screening Program, volunteer dermatologists provide free skin cancer screenings in their communities. The public can visit www.aad.org to find a free skin cancer screening in their area.

For more information about skin cancer, please visit the SkinCancerNet section of www.SkinCarePhysicians.com, a Web site developed by dermatologists that provides patients with up-to-date information on the treatment and management of disorders of the skin, hair and nails.

Headquartered in Schaumburg, Ill., the American Academy of Dermatology (Academy), founded in 1938, is the largest, most influential, and most representative of all dermatologic associations. With a membership of more than 15,000 physicians worldwide, the Academy is committed to: advancing the diagnosis and medical, surgical and cosmetic treatment of the skin, hair and nails; advocating high standards in clinical practice, education, and research in dermatology; and supporting and enhancing patient care for a lifetime of healthier skin, hair and nails. For more information, contact the Academy at
1-888-462-DERM (3376) or www.aad.org.

]]>tag:aad.org,2009-00-04:news/releases/Dermatologists_Encourage_People_To_Screen_The_One_2009-08-04T02:23:40-08:00Consumer Alert: Dermatologists Warn Skin Cancer Is An Equal-Opportunity Health Threat2009-05-04T12:00:00-08:00
At the recent 67th Annual Meeting of the American Academy of Dermatology (Academy), research presented by dermatologist Jason K. Rivers, MD, FRCPC, FAAD, clinical professor of dermatology at the University of British Columbia in Vancouver, found a higher than expected incidence of basal cell carcinoma in a small population of women under age 40. In other research unveiled at this meeting, dermatologist Robert S. Kirsner, MD, PhD, FAAD, vice chairman and Stiefel professor in the department of dermatology and cutaneous surgery at the University of Miami Miller School of Medicine, reported the incidence of melanoma (the deadliest form of skin cancer) among Hispanics and African-Americans in Florida is higher than the national average.

Increasing Incidence of Basal Cell Carcinoma in Young Women
In order to determine the demographic and tumor characteristic changes of patients diagnosed with basal cell carcinoma and squamous cell carcinoma, Dr. Rivers conducted a retrospective chart review on 885 of his patients with diagnosed non-melanoma skin cancers from 1993 to 2005 in his Vancouver dermatology practice.

Of the 885 patient charts that were reviewed, 1,177 non-melanoma skin cancers were identified. While basal cell carcinomas and squamous cell carcinomas generally were diagnosed in the older age group of patients (60+ years of age), Dr. Rivers noticed a surprising trend of a slight increase in basal cell carcinomas in patients under age 40 (20-39 years of age).

In his practice, Dr. Rivers noted that approximately five to 10 women under age 40 were diagnosed with basal cell carcinoma per year between 1995 and 2003 – a notable observation since this type of skin cancer generally affects older people. In fact, women in all age groups developed an increasing number of basal cell carcinomas over the decade studied, whereas the rate of this particular skin cancer in men remained stable.

“Although the actual number of young women diagnosed with basal cell carcinoma was relatively low, it is disturbing that we noticed a consistent increase in these numbers given that this type of non-melanoma skin cancer is a result of intermittent damage from ultraviolet radiation early in life,” explained Dr. Rivers. “This means that young people are getting enough ultraviolet exposure at a very young age to cause the development of skin cancers that normally do not occur until later in life or generally in people over age 40.”

Since Vancouver is a low sunlight area, Dr. Rivers speculated that the young women diagnosed with basal cell carcinoma in his practice could be getting more ultraviolet (UV) radiation from tanning beds, which studies show is also linked to an increased risk in melanoma.

“I think these findings of an increased incidence of basal cell carcinomas in younger people is representative of what you would find across North America if a large-scale study was conducted,” said Dr. Rivers. “We probably would notice even higher rates in areas where year-round sun exposure is more prevalent, such as the southern parts of the United States.”

Dr. Rivers added that it is important for young people to be vigilant about practicing proper sun protection and limiting their sun exposure, whether to natural or artificial sunlight. This advice is especially important for people diagnosed with skin cancer, as non-melanoma skin cancer increases a person’s risk for developing future skin cancers, including melanoma.

Increasing Rates of Melanoma in People of Color
According to estimates from the American Cancer Society, one American dies of melanoma almost every hour (every 62 minutes). While melanoma can strike anyone, Caucasians are more likely to be diagnosed with melanoma than other races. However, new research suggests that melanoma rates among Hispanics and African-Americans may be increasing in certain populations.

In a study comparing state and national melanoma incidence trends, Dr. Kirsner examined data from the Florida Cancer Data System (FCDS) and the National Cancer Institute’s Surveillance, Epidemiology and End Results (SEER) program that compiles cancer statistics from geographic areas across the country – representing 26 percent of the U.S. population. A retrospective trend analysis comparing age-adjusted, race/ethnic- and gender-specific invasive cutaneous melanoma incidence rates in Florida versus the general U.S. population were computed for the years 1992-2004.

When melanoma rates in Hispanic males were compared, the incidence of melanoma among this group was elevated in Florida. Specifically, Dr. Kirsner reported that the incidence of melanoma among male Hispanic patients residing in Florida was 20 percent higher than that of their counterparts in the SEER program. In the African-American population, black female patients in Florida had a 60 percent higher incidence of melanoma than that of black female patients reported in the SEER program – representing a significant difference in melanoma rates.

“Numerous studies also show that because of the perceived low risk of melanoma in Hispanics and African-Americans in the U.S., these patients are diagnosed later when melanoma is more advanced and much more likely to spread. As a result, they have poorer outcomes than Caucasians,” said Dr. Kirsner. “We hope that earlier diagnosis of melanoma in black and Hispanic patients at a more favorable or treatable stage will ultimately improve melanoma survival rates in minority populations. Clearly, it is important for people of all races and ethnicities to protect their skin from ultraviolet light and to make an appointment to see a dermatologist at the first sign of a suspicious mole.”

To educate the Hispanic population, the Academy is working with the National Alliance for Hispanic Health on its skin cancer public education initiative.

Monday, May 4, is Melanoma Monday® and the official launch of Melanoma/Skin Cancer Detection and Prevention Month®. Visit www.melanomamonday.org to find out how to perform a skin self-exam, download a body mole map to track changes in your skin or find free skin cancer screenings in your area. For more information on skin cancer, go to the “SkinCancerNet” section of www.skincarephysicians.com, a Web site developed by dermatologists that provides patients with up-to-date information on the treatment and management of disorders of the skin, hair and nails.

Headquartered in Schaumburg, Ill., the American Academy of Dermatology (Academy), founded in 1938, is the largest, most influential, and most representative of all dermatologic associations. With a membership of more than 15,000 physicians worldwide, the Academy is committed to: advancing the diagnosis and medical, surgical and cosmetic treatment of the skin, hair and nails; advocating high standards in clinical practice, education, and research in dermatology; and supporting and enhancing patient care for a lifetime of healthier skin, hair and nails. For more information, contact the Academy at 1-888-462-DERM (3376) or www.aad.org. ]]>tag:aad.org,2009-00-04:news/releases/Consumer_Alert_Dermatologists_Warn_Skin_Cancer_Is_2009-04-29T02:36:50-08:00Early Detection Of Melanoma Plus Regular Skin Exams Is Vital For Beating Disease2009-05-04T12:00:00-08:00
Dermatologist Gary S. Rogers, MD, FAAD, professor of dermatology and surgery at Tufts University School of Medicine in Boston, and dermatologist Jason K. Rivers, MD, FAAD, clinical professor of dermatology at the University of British Columbia in Vancouver, reviewed the most common treatments for the different stages of melanoma and offered suggestions for melanoma patients aiming for their five-year survival mark.

Melanoma Treatments Vary Depending on Stage
When detected in its earliest stages (stage 0 – stage I), melanoma is highly curable. In fact, the American Cancer Society estimates that the average five-year survival rate for individuals whose melanoma is localized and has not spread beyond the outer layers of the skin is 99 percent. Dr. Rogers explained that for patients diagnosed with a stage 0 or stage I melanoma, a routine, typically office-based surgical procedure to remove the tumor and a margin of normal-looking skin around it is performed and neither chemotherapy nor radiation is required.

In special circumstances where a melanoma occurs on a cosmetically or functionally critical site, such as the lip, nose, eyelid or finger, Dr. Rogers noted that a new technology based on a variation of Mohs surgery is being used successfully. The procedure uses an anti-melanoma targeted antibody known as MART-1 (Melanoma Antigen Recognized by T cells), which improves the speed and accuracy of the procedure. The technique allows the surgeon to microscopically identify and remove the melanoma cells with minimal sacrifice of healthy tissues in real-time (16-20 minutes). The ability to successfully resect (or surgically remove) the cancer with potentially an 1/8 inch margin rather than an inch margin is critical when working on delicate structures such as an eyelid, said Rogers.

For stage II melanomas, surgery is performed to remove the tumor and surrounding tissue. In addition, the dermatologic surgeon often tests the lymph nodes to determine if the cancer has spread. If the melanoma is going to spread, Dr. Rogers noted that 57 percent of the time the first place the cancer goes is to the local draining lymph nodes. A procedure known as a sentinel lymph node biopsy tests the first lymph nodes into which the melanoma drains. If the lymph nodes are free of cancer cells, then the melanoma is considered in stage II with an average five-year survival rate of 70 percent. In this stage, Dr. Rogers explained that interferon may be given as an adjuvant (or drug-enhancing agent) to boost the patient’s immune system.

However, if the lymph nodes are determined to be involved, then the melanoma is classified as stage III. In this stage, the cancer has spread to one or more nearby lymph nodes and the average five-year survival rate drops to 50 percent or less. Once a melanoma has spread beyond the skin growth, a more extensive treatment plan – which may include surgical removal of the tumor with wide margins, usually including the affected regional lymph nodes; chemotherapy; immunotherapy or radiation therapy – is often indicated.

When the tumor has spread to a distant site, such as the lung, brain or other organ, this is considered a stage IV melanoma with an average survival rate of only 10 months. One drug being used to treat patients with advanced melanoma is known as dacarbazine or DTIC. However, the remission rate with this drug is only 10 percent.

“No studies to date show that chemotherapy or any treatment regimens are effective when melanoma has spread to other organs,” said Dr. Rogers. “The silver lining is that given the explosion in our understanding of the molecular biology of melanoma, there are a number of drugs and therapies in the pipeline that are being studied to treat the more advanced stage melanomas.”

One potential therapy involves targeting specific drugs to specific genes that are known to go awry in the development of melanoma. There are multiple genes involved in melanoma progression from local tumor to disseminated disease. And, on a molecular level, there are many differences between melanomas that form in chronically sun-exposed areas versus areas of the body that are not sun-exposed, such as the soles or palms. The goal is to find a drug that will target a specific type of gene defect responsible for certain types of melanoma. “Just as one shoe does not fit all sizes, we are on the verge of being able to tailor therapy to a particular patient,” added Dr. Rogers.

Clinical trials also are underway to test a vaccine known as the MAGE-A (melanoma antigen – family A) vaccine that would be used as an adjuvant to treat certain types of stage III and IV melanoma. MAGE is an antigen that exists in every cell in the body, but it is not expressed (or made apparent as an observable inherited characteristic) except in cancer. The gene that produces the MAGE protein lies dormant but becomes activated on the surface of melanoma cells and other cancers. Now, this vaccine is being tested to target cells that express or produce inherited characteristics of the MAGE antigen. Dr. Rogers estimated that 60 to 70 percent of melanoma patients express the MAGE antigen, and he believes the vaccine could hold tremendous promise in treating more advanced melanomas in the future.

Tips for Melanoma Survivors: Remain Vigilant
Individuals diagnosed with melanoma are at risk for developing another melanoma and other types of cancer. Dr. Rivers explained that melanoma patients, especially those with atypical moles, are at increased risk for melanoma of the eyes. He reported that studies also show that melanoma seems to
increase the likelihood of contracting breast cancer and possibly some lymphomas. In families where more than one family member has melanoma, Dr. Rivers said these patients also are at increased risk for developing pancreatic cancer.

“Once a patient is diagnosed with melanoma, he or she should be checked by a dermatologist as often as every three months to once a year, depending on the individual’s prognosis,” said Dr. Rivers. “The most important factor in beating melanoma and improving survival rates is increased public awareness, as this has been shown to save lives by identifying melanoma at an early, curable stage.”
In his practice, Dr. Rogers offers tips for melanoma survivors that he personally believes are good for their overall health. These include:
  • Eating foods rich in anti-oxidants, such as legumes, kale, green leafy vegetables, carrots, fish (especially salmon), fruits, whole grains, and flax seed.
  • Taking recommended daily doses of anti-oxidant supplements, including beta carotene, selenium, vitamin C, vitamin E and fish oils (also known as EPA).
  • Drink one to two glasses of red wine a day. Resveratrol, a polyphenol found in the skins of grapes (part of the plant’s immune system), has potent anti-cancer properties and becomes concentrated in red wine during the fermentation process.
  • Avoiding other forms of alcohol other than red wine, as alcohol in general is detrimental to a person’s health in many ways and suppresses the immune system.

“I always tell my melanoma patients to remain hopeful and vigilant, and see your dermatologist regularly,” added Dr. Rogers. “Even if you beat melanoma once, you have an increased risk of getting another one in the future. With melanoma, you can never let your guard down.” 

Monday, May 4, is Melanoma Monday® and the official launch of Melanoma/Skin Cancer Detection and Prevention Month®. Visit www.melanomamonday.org to find out how to perform a skin self-exam, download a body mole map to track changes in your skin and find free skin cancer screenings in your area. For more information on skin cancer, go to the “SkinCancerNet” section of www.skincarephysicians.com, a Web site developed by dermatologists that provides patients with up-to-date information on the treatment and management of disorders of the skin, hair and nails.

Headquartered in Schaumburg, Ill., the American Academy of Dermatology (Academy), founded in 1938, is the largest, most influential, and most representative of all dermatologic associations. With a membership of more than 15,000 physicians worldwide, the Academy is committed to: advancing the diagnosis and medical, surgical and cosmetic treatment of the skin, hair and nails; advocating high standards in clinical practice, education, and research in dermatology; and supporting and enhancing patient care for a lifetime of healthier skin, hair and nails. For more information, contact the Academy at
1-888-462-DERM (3376) or www.aad.org.

]]>tag:aad.org,2009-00-04:news/releases/Early_Detection_Of_Melanoma_Plus_Regular_Skin_Exam2009-04-29T02:53:42-08:00